Advertisement

N

  • J. Elks
  • C. R. Ganellin

Keywords

Antibacterial Agent Antihypertensive Agent Yellow Cryst Industrial Material Narcotic Antagonist 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Razdan, R.K. et al, J. Med. Chem., 1976, 19, 454 (synth, pharmacol)Google Scholar
  2. Lemberger, L. et al, Clin. Pharmacol. Ther., 1975, 18, 720 (pharmacol)Google Scholar
  3. U.S.P., 3 953 603, (1976); CA, 85, 25405d (synth)Google Scholar
  4. Archer, R.A. et al, J. Org. Chem., 1977, 42, 2277 (synth)Google Scholar
  5. Souter, R.W., Anal. Profiles Drug Subst., 1981, 10, 499 (rev, synth, props, pharmacol)Google Scholar
  6. Byrn, S.R. et al, J. Pharm. Sci., 1985, 74, 565 (cmr)Google Scholar
  7. Ward, A. et al, Drugs, 1985, 30, 127 (pharmacol)Google Scholar
  8. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 843.Google Scholar
  9. Howes, J.F., Cannabinoids: Chem., Pharmacol., Ther. Aspects, 1982, 881.Google Scholar
  10. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 12989.Google Scholar
  11. Condon, M.E. et al, J. Med. Chem., 1978, 21, 913 (pharmacol, synth)Google Scholar
  12. Funke, P.T. et al, J. Pharm. Sci., 1978, 67, 653 (ms)Google Scholar
  13. Heel, R.C. et al, Drugs, 1980, 1, 1 (pharmacol)Google Scholar
  14. Slusarek, L. et al, Anal. Profiles Drug Subst., 1980, 9, 455 (rev)Google Scholar
  15. Matsutero, E. et al, J. Chromatogr., 1981, 216, 374 (sepn)Google Scholar
  16. Aboul-Enein, H.Y. et al, Spectrosc. Lett., 1983, 16, 151 (nmr)Google Scholar
  17. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 6315.Google Scholar
  18. U.S.P., 3 637 830, (1972); CA, 76, 85597a (synth)Google Scholar
  19. Duteil, J. et al, Therapie, 1973, 28, 703 (pharmacol)Google Scholar
  20. Ger. Pat., 2 453 745, (1976); CA, 85, 62850r (synth) Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 12992.Google Scholar
  21. Goldberg, S.D. et al, J. Am. Chem. Soc., 1937, 59, 2280 (synth, lox, pharmacol)Google Scholar
  22. Kreider, H.R. et al, J. Am. Chem. Soc., 1942, 64, 1227 (struct)Google Scholar
  23. Buechi, J. et al, Arzneim.-Forsch., 1964, 14, 161; 1966, 16, 1657 (props)Google Scholar
  24. Norris, W.R. et al, J. Pharm. Sci., 1965, 54, 995 (derivs)Google Scholar
  25. Fujii, S. et al, Proteinase Inhib., 1983, 37 (rev, pharmacol)Google Scholar
  26. Aoyama, T. et al, Jpn. J. Pharmacol., 1984, 35, 203 (pharmacol)Google Scholar
  27. Aoyama, T. et al, Chem. Pharm. Bull., 1985, 33, 1458 (synth, pharmacol)Google Scholar
  28. Oka, T. et al, Life Support Syst., 1986, 4, 195 (rev)Google Scholar
  29. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 1775.Google Scholar
  30. Nestor, J.J. et al, J. Med. Chem., 1982, 25, 795 (synth, pharmacol)Google Scholar
  31. Chan, R.L. et al, Drug Metab. Dispos., 1985, 13, 566 (metab)Google Scholar
  32. Nilius, S.J. et al, J. Steroid Biochem., 1985, 23, 779, 849 (revs)Google Scholar
  33. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 16907.Google Scholar
  34. Seuter, F. et al, Arzneim.-Forsch., 1979, 29, 54 (pharmacol)Google Scholar
  35. Seuter, F. et al, New Cardiovasc. Drugs, 1986, 163 (rev)Google Scholar
  36. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 12993.Google Scholar
  37. B.P., 880 400, (1961); CA, 57, 13763 (synth)Google Scholar
  38. Brain, E.G. et al, J. Chem. Soc., 1963, 491 (synth)Google Scholar
  39. Walkenstein, S.S. et al, J. Pharm. Sci., 1963, 52, 763 (metab)Google Scholar
  40. Glassman, J.M. et al, Toxicol. Appl. Pharmacol., 1964, 6, 1220 (pharmacol)Google Scholar
  41. Branpain, P.C. et al, J. Med. Chem., 1980, 23, 1283 (cryst struct)Google Scholar
  42. Ohashi, M. et al, J. Pharm. Sci., 1983, 72, 508 (ms)Google Scholar
  43. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 110.Google Scholar
  44. Bencze, W.L. et al, Tetrahedron, 1970, 26, 5407 (synth, config, ord)Google Scholar
  45. Bianchine, J.R. et al, Clin. Pharmacol. Ther., 1970, 11, 97 (metab)Google Scholar
  46. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 1351.Google Scholar
  47. Vecchietti, V. et al, Eur. J. Med. Chem.-Chim. Ther., 1974, 9, 501.Google Scholar
  48. Tajana, A. et al, Boll. Chim. Farm., 1981, 120, 185 (synth, pharmacol)Google Scholar
  49. Walker, K.A. et al, J. Med. Chem., 1981, 24, 67 (synth, pharmacol)Google Scholar
  50. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 19553.Google Scholar
  51. B.P., 1 016 968, (1966); CA, 64, 11225f (synth)Google Scholar
  52. Pala, C. et al, Farmaco, Ed. Sci., 1967, 22, 3 (resoln)Google Scholar
  53. Turba, C. et al, Arzneim.-Forsch., 1966, 16, 386 (pharmacol)Google Scholar
  54. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 12994.Google Scholar
  55. U.S.P., 3 937 720, (1976); CA, 85, 21722g (synth, pharmacol)Google Scholar
  56. U.S.P., 3 284 299, (1966); CA, 65, 669 (synth)Google Scholar
  57. Beaudet, C. et al, CA, 1970, 73, 87678 (synth, props)Google Scholar
  58. Ueda, T. et al, Yakugaku Zasshi, 1971, 91, 1244 (synth)Google Scholar
  59. Delwaide, P.A. et al, Arch. Int. Pharmacodyn. Ther., 1974, 208, 357 (props)Google Scholar
  60. Alhadeff, M., Drugs of Today, 1977, 13, 538 (rev)Google Scholar
  61. Bressolle, F. et al, Farmaco, Ed. Prat., 1985, 40, 187 (props)Google Scholar
  62. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 1724.Google Scholar
  63. Szarvasi, E. et al, Bull. Soc. Chim. Fr., 1966, 1838 (synth)Google Scholar
  64. Heindrich, H. et al, Arzneim.-Forsch., 1972, 22, 1001 (pharmacol)Google Scholar
  65. Beghi, E. et al, Clin. Pharmacol. Drug Epidemiol., 1979, 2, 211 (rev)Google Scholar
  66. Garrett, E.R. et al, J. Pharm. Sci., 1984, 73, 635 (pharmacol)Google Scholar
  67. Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th Ed., Akademie-Verlag, Berlin, 1987, 7174.Google Scholar
  68. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 9256.Google Scholar
  69. B.P., 1 579 879, (1977); CA, 88, 62215z (synth, pharmacol)Google Scholar
  70. Georgopoulos, A. et al, Antimicrob. Agents Chemother., 1981, 19, 386, 390 (pharmacol)Google Scholar
  71. Ryder, N.S. In Vitro In Vivo Eval. Antifungal Agents, Proc. Int. Symp., 1985, 89 (rev)Google Scholar
  72. Stütz, A. et al, J. Med. Chem., 1986, 29, 112 (synth)Google Scholar
  73. Stütz, A., Angew. Chem., Int. Ed. Engl., 1987, 26, 320 (rev) Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 12995.Google Scholar
  74. U.S.P., 3 997 666, (1976); CA, 83, 179122e (synth) Anon., Drugs Future, 1987, 12, 31 (rev)Google Scholar
  75. Ger. Pat., 2 028 528, (1971); CA, 76, 59600t (synth, pharmacol)Google Scholar
  76. Casadio, S. et al, J. Med. Chem., 1965, 8, 594 (synth, pharmacol)Google Scholar
  77. Coppi, G., Arch. Int. Pharmacodyn. Ther., 1966, 162, 378, 398, 413, 422 (pharmacol)Google Scholar
  78. Marazzi-Uberti, E. et al, Arzneim.-Forsch., 1967, 17, 1451 (tox)Google Scholar
  79. Lumachi, B. et al, Arch. Int. Pharmacodyn. Ther., 1970, 186, 66 (pharmacol)Google Scholar
  80. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 12996.Google Scholar
  81. B,HCI: [23277–43–2]. En 2234A. Nalbuphine hydrochloride, USAN. Nubain.Google Scholar
  82. B.P., 1 119 270, (1968); CA, 69, 87282q (synth)Google Scholar
  83. Elliot, H.W. et al, J. Med. (Basel), 1970, 1, 74 (pharmcol)Google Scholar
  84. Brouant, P. et al, Ann. Pharm. Fr., 1979, 37, 461 (conformn, cryst struct)Google Scholar
  85. Miller, R.R., Am. J. Hosp. Pharm., 1980, 37, 942 (rev)Google Scholar
  86. Errick, J.K. et al, Drugs, 1983, 26, 191 (activity, toxicity)Google Scholar
  87. Fahmy, N.R., Clin. Anaesthesiol., 1983, 1, 164 (rev)Google Scholar
  88. Olofson, R.A. et al, J. Org. Chem., 1984, 49, 2081 (synth)Google Scholar
  89. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 6244.Google Scholar
  90. Lesher, G.Y. et al, J. Med. Chem., 1962, 5, 1063.CrossRefGoogle Scholar
  91. Santielli, A.A. et al, J. Med. Chem., 1975, 18, 1038 (synth)Google Scholar
  92. Lesher, G.Y., Kirk-Othmer Encycl. Chem. Technol., 3rd Ed., 1978, 2, 782 (rev)Google Scholar
  93. Grubb, P.E., Anal. Profiles Drug Subst., 1979, 8, 371 (rev)Google Scholar
  94. Huber, C.P. et al, Acta Crystallogr., Sect. B, 1980, 36, 497 (cryst struct)Google Scholar
  95. Koch, H. et al, Pharm. Int., 1980, 1, 108 (rev, pharmacol)Google Scholar
  96. Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th Ed., Akademie-Verlag, Berlin, 1987, 2267.Google Scholar
  97. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 5663.Google Scholar
  98. B,HBr: [1041–90–3]. Lethidrone. Sol. H2O. Mp 258–259° dec.Google Scholar
  99. B,HCI: [57–29–4]. Nalorphine hydrochloride, USAN. Miromorfalil. Naline. Sol. H2O. Mp 260–263°.Google Scholar
  100. Narcotic analgesic. Antidote. Rhombs. (EtOH). Mp 134–135°.Google Scholar
  101. Di–O–Ac; B,HCI: Needles (EtOH). Mp 227–229°. Dinicotinoyl: [3194–25–0].Google Scholar
  102. Dinicotinoyl; B,HCI: Cryst. (EtOH). Mp 238–239°.Google Scholar
  103. Jacobson, A.E. et al, Chemical and Biological Aspects of Drug Dependency, (Mule, S.T., Ed.), CRC Press, 101 (rev, pharmacol)Google Scholar
  104. Weijlard, J. et al, J. Am. Chem. Soc., 1942, 64, 869 (synth)Google Scholar
  105. Green, A.F. et al, J. Pharm. Pharmacol., 1954, 6, 390 (deny)Google Scholar
  106. Lasagna, L., Arch. Intern. Med., 1954, 94, 532 (rev)Google Scholar
  107. Pongratz, A. et al, Monatsh. Chem., 1960, 91, 396 (deny)Google Scholar
  108. Payne, J.P., Br. J. Anaesth., 1973, 45 (Suppl.), 794 (rev)Google Scholar
  109. Olofson, R.A. et al, Tetrahedron Leu., 1977, 1571 (synth)Google Scholar
  110. Gelders, Y.G. et al, Cryst. Struct. Commun., 1979, 8, 995 (cryststruct)Google Scholar
  111. Crone, T.A. et al, Anal. Chem., 1981, 53, 17 (cd)Google Scholar
  112. Eliel, E.L. et al, Org. Magn. Reson., 1984, 22, 258 (cmr, conformn)Google Scholar
  113. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 7304.Google Scholar
  114. Sax, N.I., Dangerous Properties of Industrial Materials, 6th Ed., Van Nostrand-Reinhold, 1984, 1970.Google Scholar
  115. B,HCI: [357–08–4]. Naloxone hydrochloride, USAN. Nalonee. Narcan. Narcanti. EN 1530. Cryst. (EtOH/Et20). Sol. H2O, insol. Et20. Mp 200–205°.Google Scholar
  116. B.P., 955 493, (1964); CA, 61, 4410 (synth)Google Scholar
  117. Sime, R.L., Acta Crystallogr., Sect. B, 1975, 31, 4410 (cryst struct)Google Scholar
  118. Jacob, J.J. et al, Arch. Int. Pharmacodyn. Ther., 1976, 222, 332 (pharmacol)Google Scholar
  119. Crabbendam, P.R. et al, Red. Tray. Chim. Pays-Bas, 1983, 102, 135 (synth, pmr)Google Scholar
  120. McNicholas, L.F. et al, Drugs, 1984, 29, 81 (rev, pharmacol)Google Scholar
  121. Milne, B. et al, Can. Anaesth. Soc. J., 1984, 31, 272 (rev)Google Scholar
  122. Hassan, M.M.A. et al, Anal. Profiles Drug Subst., 1985, 14, 453 (rev)Google Scholar
  123. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 7306.Google Scholar
  124. Sax, N.I., Dangerous Properties of Industrial Materials, 6th Ed., Van Nostrand-Reinhold, 1984, 1970.Google Scholar
  125. U.S.P., 3 332 950, (1967); CA, 67, 100301a (synth, pharmacol)Google Scholar
  126. Carroll, F.I. et al, J. Org. Chem., 1976, 41, 996 (cmr)Google Scholar
  127. Gritz, E.R. et al, Clin. Pharmacol. Ther., 1976, 19, 773 (pharmacol)Google Scholar
  128. Loew, G.H. et al, J. Med. Chem., 1978, 21, 101 (conformn)Google Scholar
  129. Kotick, M.P. et al, J. Med. Chem., 1981, 24, 1445 (synth, metab)Google Scholar
  130. Pinkert, T.M. et al, Clin. Anaesthesiol., 1983, 1, 168 (rev, pharmacol)Google Scholar
  131. Christian, M.S., J. Clin. Psychiatry, 1984, 45, 7 (rev, toxicol)Google Scholar
  132. Crabtree, B.L. et al, Clin. Pharm., 1984, 3, 273 (rev, pharmacol)Google Scholar
  133. Olafson, R.A. et al, J. Org. Chem., 1984, 49, 2081 (synth)Google Scholar
  134. Wall, M.E. et al, Drug Metab. Dispos., 1984, 12, 677 (metab)Google Scholar
  135. Burke, T.R. et al, Heterocycles, 1985, 23, 99 (synth) Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 7307.Google Scholar
  136. Portoghese, P. et al, Eur. J. Pharmacol., 1988, 146, 185.CrossRefGoogle Scholar
  137. Portoghese, P. et al, J. Med. Chem., 1988, 31, 281.CrossRefGoogle Scholar
  138. Omura, S. et al, J. Antibiot., 1974, 27, 363 (iso!)Google Scholar
  139. Tanaka, H. et al, J. Antibiot., 1975, 28, 860, 868 (isol, props, struct, biosynth)Google Scholar
  140. Tanaka, H. et al, J. Antibiot., 1975, 28, 925 (derio)Google Scholar
  141. Li, T.-T. et al, J. Am. Chem. Soc., 1978, 100, 6263 (synth)Google Scholar
  142. Iwai, Y. et al, J. Antibiot., 1983, 36, 1268 (isol, derius)Google Scholar
  143. Kometani, T. et al, J. Org. Chem., 1983, 48, 2630 (synth)Google Scholar
  144. Japan. Pats., 84 48 484, 84 48 478, 84 48 477, (1984); CA, 101,88834, 88835, 88836 (iso!)Google Scholar
  145. Semmelhack, M.F. et al, Tetrahedron, 1985, 41, 5803 (synth)Google Scholar
  146. Tatsuta, K. et al, Bull. Chem. Soc. Jpn., 1985, 58, 1699 (synth)Google Scholar
  147. Yoshii, E. et al, Chem. Pharm. Bull., 1985, 33, 4779 (synth)Google Scholar
  148. Kraus, G.A et al, J. Chem. Soc., Chem. Commun., 1986, 1568 (synth)Google Scholar
  149. Decker, O.H.W. et al, J. Org. Chem., 1987, 26, 1174 (synth)Google Scholar
  150. Kraus, G.A. et al, J. Org. Chem., 1987, 52, 1273 (synth)Google Scholar
  151. Eur. Pat., 166 533, (1986); CA, 105, 115061 (synth, pharmacol)Google Scholar
  152. Ger. Pat., 2 722 383, (1976); CA, 88, 89533p (synth, pharmacol)Google Scholar
  153. Milne, G.M. et al, NIDA Res. Monogr., 1979, 27, 84 (pharmacol)Google Scholar
  154. Johnson, M.R. et al, J. Heterocycl. Chem., 1980, 17, 1817 (synth)Google Scholar
  155. Mcllhenny, H.M. et al, J. Pharmacol. Exp. Ther., 1981, 219, 363 (pharmacol)Google Scholar
  156. Howlett, A.C. et al, Mol. Pharmacol., 1984, 26, 532 (pharmacol)Google Scholar
  157. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 12896.Google Scholar
  158. B,HC1: [57166–13–9]. Napactadine hydrochloride, USAN. DL–588. Cryst. (2–propanol). Mp 223.5–224.5°.Google Scholar
  159. U.S.P., 3 903 163, (1975); CA, 83, 192933q (synth, pharmacol) Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 12999.Google Scholar
  160. Wentland, M.P. et al, J. Med. Chem., 1987, 30, 1482 (synth, pharmacol)Google Scholar
  161. Ger. Pat., 962 608, (1957); CA, 51, 15588 (synth) Gatterdan, P.E. et al, J. Econ. Entomol., 1962, 55, 326 (pharmacol)Google Scholar
  162. Werbel, L.M. et al, J. Med. Chem., 1966, 10, 32 (synth) Gupta, S.P. et al, Indian J. Chem., Sect. B, 1977, 15, 731 (struct, activity)Google Scholar
  163. Himel, C.M. et al, Pestic. Biochem. Physiol., 1982, 17, 103 (activity)Google Scholar
  164. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 13000.Google Scholar
  165. Fusco, R. et al, Gazz. Chim. Ital., 1957, 87, 438 (synth) Bennett, G.B. et al, J. Med. Chem., 1978, 21, 623 (synth)Google Scholar
  166. Danish Pat., 62 889, (1945); CA, 40, 4398 (synth)Google Scholar
  167. Villa, L. et al, Farmaco, Ed. Sci., 1967, 22, 491 (pharmacol) Kracmar, J. et al, Cesk. Farm., 1972, 21, 48 (uv)Google Scholar
  168. Pullman, B. et al, J. Med. Chem., 1972, 15, 17 (struct) Piskov, V.B. et al, Khim. Prir. Soedin., 1976, 8, 1112 (synth)Google Scholar
  169. De Jong, A.P. et al, J. Med. Chem., 1979, 22, 1290 (struct)Google Scholar
  170. Podder, A. et al, Acta Crystallogr., Sect. C, 1983, 39, 495 (cryststruct)Google Scholar
  171. Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th Ed., Akademie-Verlag, Berlin, 1987, 3087.Google Scholar
  172. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 2085, 2086.Google Scholar
  173. Gardiner, F.E. et al, Science, 1939, 90, 208 (use)Google Scholar
  174. Ogata, Y. et al, J. Am. Chem. Soc., 1950, 72, 4302 (synth)Google Scholar
  175. Hitzenberger, G. et al, Wien. Med. Wochschr., 1958, 108, 504; 1959, 109, 707 (pharmacol)Google Scholar
  176. Org. Synth., 1970, 50, 77 (synth, ester)Google Scholar
  177. Gore, R.C. et al, J. Assoc. Off. Anal. Chem., 1971, 54, 1040 (uv, ir)Google Scholar
  178. Rajan, S.S., Acta Crystallogr., Sect. B, 1978, 34, 998 (cryst struct)Google Scholar
  179. Pesticide Manual, 6th Ed., 376.Google Scholar
  180. Sax, N.I., Dangerous Properties of Industrial Materials, 6th Ed., Van Nostrand-Reinhold, 1984, 1971, 1972.Google Scholar
  181. Ger. Pat., 2 501 122, (1975); CA, 84, 44076t (synth, pharmacol)Google Scholar
  182. Eckstein, M. et al, CA, 1959, 53, 6175 (synth)Google Scholar
  183. Shapiro, S.L. et al, J. Org. Chem., 1960, 25, 1860; 1961, 26, 3580 (synth, props)Google Scholar
  184. Perjessy, A. et al, Tetrahedron, 1971, 27, 6159 (ir)Google Scholar
  185. Fanelli, O., Arzneim.-Forsch., 1975, 25, 873 (pharmacol)Google Scholar
  186. Csoregh, I. et al, Acta Crystallogr., Sect. B, 1979, 35, 852 (cryststruct)Google Scholar
  187. Murthy, A.R. et al, J. Med. Chem., 1985, 28, 1591 (synth, props)Google Scholar
  188. Cpd. with morpholine: [70696–67–2]. Cryst. (MeZCO). Mp 155°.Google Scholar
  189. Belg. Pat., 870 910, (1979); CA, 91, 39315 (synth)Google Scholar
  190. U.S.P., 4 617 315, (1986); CA, 106, 23301 (pharmacol)Google Scholar
  191. Harrison, I.T. et al, J. Med. Chem., 1970, 13, 203 (synth)Google Scholar
  192. Riegl, J. et al, J. Med. Chem., 1974, 17, 377 (abs config)Google Scholar
  193. Dorfman, R.I.,Arzneim.-Forsch., 1975, 25, 281 (rev)Google Scholar
  194. Lombardino, J.G. et al, Arzneim.-Forsch., 1975, 25, 1629 (props)Google Scholar
  195. Elden, F. et al, Pharm. Ztg., 1978, 123, 1796 (uv, ir, pmr)Google Scholar
  196. Arai, N. et al, Tetrahedron Lett., 1983, 24, 1531 (synth)Google Scholar
  197. Ravikumar, K. et al, Acta Crystallogr., Sect. C, 1985, 41, 280 (cryst struct)Google Scholar
  198. Gu, Q.-M. et al, Tetrahedron Lett., 1986, 27, 1763 (synth)Google Scholar
  199. Castaldi, G. et al, J. Org. Chem., 1987, 52, 3018 (synth)Google Scholar
  200. Piccolo, O. et al, J. Org. Chem., 1987, 52, 10 (synth)Google Scholar
  201. Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th Ed., Akademie-Verlag, Berlin, 1987, 3107.Google Scholar
  202. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 2672, 2673.Google Scholar
  203. Dorman, D.E. et al, Heiv. Chico. Acta, 1976, 59, 2625 (biosynth)Google Scholar
  204. Occolowitz, J.K. et al, Biomed. Mass Spectrom., 1976, 3, 272 (struct)Google Scholar
  205. Seto, H.et al, J. Antibiot., 1977, 30, 530 (cmr, struct)Google Scholar
  206. U.S.P., 4 035 481, (1977); CA, 87, 116418 (isol)Google Scholar
  207. Berg, D.H. et al, J. Antibiot., 1978, 31, 1 (isol, struct)Google Scholar
  208. U.S.P., 4 141 907, (1979); CA, 91, 122144 (isol, props, clerk)Google Scholar
  209. Caughey, B. et al, Biochem. Biophys. Res. Commun., 1983, 113, 832 (pmr, conformn)Google Scholar
  210. Lewis, M.D. et al, Diss. Abstr. Int. B, 1983, 44, 1829 (rev, synth)Google Scholar
  211. Rabe, P. et al, Justus Liebigs Ann. Chem., 1910, 377, 223 (struct, bibi)Google Scholar
  212. Addinall, C.R. et al, J. Am. Chem. Soc., 1933, 55, 1202, 2153 (isol, synth)Google Scholar
  213. Briggs, L.H. et al, Anal. Chem., 1957, 29, 904 (ir)Google Scholar
  214. Klötzer, W. et al, Monatsh. Chem., 1972, 103, 1210 (synth, uv, ir, pmr)Google Scholar
  215. Blaskö, G. et al, J. Org. Chem., 1982, 47, 880 (synth, uv, pmr)Google Scholar
  216. Robiquet, M., Ann. Chim. (Paris), 1817, 5, 275 (isol)Google Scholar
  217. Perkin, W.H. et al, J. Chem. Soc., 1911, 99, 775 (synth, resoln)Google Scholar
  218. Wrede, F., Chem. Zentralbl., 1937, 1, 2611; 1938, 2, 863 (Narcotoline)Google Scholar
  219. Baumgarten, G. et al, Pharmazie, 1950, 5, 80 (Narcotoline)Google Scholar
  220. Ohta, M. et al, Tetrahedron Len., 1963, 859 (abs config)Google Scholar
  221. Ohta, M. et al, Chem. Pharm. Bull., 1964, 12, 1080 (isol)Google Scholar
  222. Battersby, A.R. et al, J. Chem. Soc., 1965, 1087 (abs config)Google Scholar
  223. Battersby, A.R. et al, J. Chem. Soc. (C), 1968, 2163 (biosynth)Google Scholar
  224. Snatzke, G. et al, Tetrahedron, 1969, 25, 5059 (ord)Google Scholar
  225. Kametani, T. et al, J. Chem. Soc., Perkin Trans. 1, 1977, 374 (synth)Google Scholar
  226. Al-Yahya, M.A. et al, Anal. Profiles Drug Subst., 1982, 11, 407 (rev, synth, props, anal)Google Scholar
  227. Blaskb, G. et al, J. Nat. Prod., 1982, 45, 105 (occur)Google Scholar
  228. Shono, T. et al, J. Org. Chem., 1983, 48, 1621 (synth)Google Scholar
  229. Moss, D.S. et al, Acta Crystallogr., Sect. C, 1984, 40, 1960 (cryst struct)Google Scholar
  230. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 5625, 5626.Google Scholar
  231. Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th Ed., Akademie-Verlag, Berlin, 1987, 6492.Google Scholar
  232. Sax, N.I., Dangerous Properties of Industrial Materials, 6th Ed., Van Nostrand-Reinhold, 1984, 2075.Google Scholar
  233. Jones, J.H. et al, J. Med. Chem., 1984, 27, 1607 (synth, pharmacol, cryst struct)Google Scholar
  234. Martin, G.E. et al, J. Pharmacol. Exp. Ther., 1984, 230, 569 (pharmacol)Google Scholar
  235. Dykstra, D. et al, Eur. J. Med. Chem.-Chim. Ther., 1985, 20, 247 (synth, pharmacol)Google Scholar
  236. Mazzo, D.J.et al, J. Chromatogr., 1986, 367, 405 (hplc)Google Scholar
  237. Melillo, D.G. et al, J. Org. Chem., 1987, 52, 5143 (synth)Google Scholar
  238. Flohe, L. et al, Arzneim.-Forsch., 1983, 33, 1240 (synth, pharmacol)Google Scholar
  239. Stezowski, J.J. et al, J. Chem. Soc., Chem. Commun., 1983, 1315 (cryst struct)Google Scholar
  240. Maurin, N., Arzneim.-Forsch., 1986, 36, 1180 (pharmacol)Google Scholar
  241. Schmitz, F.J. et al, Agents Actions, 1986, 18, 113 (pharmacol)Google Scholar
  242. Gilbert, J.N.T. et al, J. Pharm. Pharmacol., 1974, 26, 119 (metab)Google Scholar
  243. Games, D.E. et al, Adv. Mass Spectrom. Biochem. Med., 1976, 1, 383 (ms)Google Scholar
  244. Stuper, A.J. et al, J. Pharm. Sci., 1978, 67, 745 (pharmacol)Google Scholar
  245. Testa, B., Pharm. Acta Helv., 1978, 53, 143 (metab) Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 4053.Google Scholar
  246. Eriksson, H.E. et al, Acta Pharm. Suec., 1976, 13, 79 (synth, pharmacol)Google Scholar
  247. Eur. Pat., 145 067, (1985); CA, 104, 5773 (synth, pharmacol)Google Scholar
  248. Stark, W.M. et al, Antimicrob. Agents Chemother., 1967, 314.Google Scholar
  249. Dorman, D.E. et al, J. Am. Chem. Soc., 1976, 98, 6885.CrossRefGoogle Scholar
  250. Koch, K.F. et al, J. Org. Chem., 1978, 43, 1430.CrossRefGoogle Scholar
  251. Konstantinova, N.V. et al, Antibiotiki (Moscow), 1982, 27, 403 (isol, props)Google Scholar
  252. Stark, W.M. et al, Antimicrob. Agents Cheomother., 1967, 314, 324, 332, 341.Google Scholar
  253. Stark, W.M. et al, Folia Microbiol. (Prague), 1971, 16, 205CrossRefGoogle Scholar
  254. Koch, K.F. et al, J. Antibiot., 1973, 26, 745.CrossRefGoogle Scholar
  255. Dorman, D.E. et al, J. Am. Chem. Soc., 1976, 98, 6885.CrossRefGoogle Scholar
  256. Miyake, T. et al, Bull. Chem. Soc. Jpn., 1977, 50, 2362 (synth, cmr)Google Scholar
  257. Okutani, T. et al, J. Am. Chem. Soc., 1977, 99, 1278 (synth)Google Scholar
  258. Koch, K.F. et a!, J. Org. Chem., 1978, 43, 1430 (cmr, nmr, ms)Google Scholar
  259. Lightbown, J.W. et al, J. Biol. Stand., 1982, 10, 157 (synth)Google Scholar
  260. Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th Ed., Akademie-Verlag, Berlin, 1987, 5084.Google Scholar
  261. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 174, 18310. Sax, N.I., Dangerous Properties of Industrial Materials, 5th Ed., Van Nostrand-Reinhold, 1979, 2586.Google Scholar
  262. Austrian Pat., 361 483, (1981); CA, 95, 7252d (synth, pharmacol)Google Scholar
  263. Japan. Pat., 5 804 722, (1983); CA, 98, 137619b (synth)Google Scholar
  264. Coltman, S.C. et al, Synthesis, 1984, 150 (ester)Google Scholar
  265. Cairns, H. et al, J. Med. Chem., 1985, 28, 1832 (ester)Google Scholar
  266. Freer, A.A. et al, Acta Crystallogr., Sect. C, 1987, 43, 1900 (cryst struct)Google Scholar
  267. U.S.P., 4 338 317, (1982); CA, 97, 182432a (synth, ir, pmr, pharmacol)Google Scholar
  268. B,HCI: [86015–38–5]. Neflumozide hydrochloride, USAN. HRP 913. P 793913. Cryst. (EtOAc/MeOH). Mp 255–257°.Google Scholar
  269. Fielding, S. et al, Drug Dey. Res., 1983, 3, 233 (pharmacol)Google Scholar
  270. U.S.P., 4 390 544, (1983); CA, 99, 122548 (synth, pharmacol)Google Scholar
  271. B, HCI: [23327–57–3]. Nefopam hydrochloride, USAN. Acupan. Numerous proprietary names. Mp 238–242°. DDM4200000.Google Scholar
  272. Bassett, J.R. et al, Br. J. Pharmacol., 1969, 37, 69 (pharmacol)Google Scholar
  273. U.S.P., 3 487 153, (1969); CA, 72, 79124m (synth)Google Scholar
  274. Heel, R.C. et al, Drugs, 1980, 19, 249 (rev, pharmacol)Google Scholar
  275. Brenner, J.B.et al, Aust. J. Chem., 1982, 35, 2307 (synth)Google Scholar
  276. Hansen, L.K. et al, Acta Chem. Scand., Ser. B, 1984, 38, 327 (cryst struct, abs config)Google Scholar
  277. Kluefers, P. et al, Arch. Pharm. (Weinheim, Ger.), 1986, 319, 583 (conformn, cryst struct)Google Scholar
  278. Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th Ed., Akademie-Verlag, Berlin, 1987, 4375.Google Scholar
  279. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 2674.Google Scholar
  280. U.S.P., 4 112 112, (1978); CA, 91, 91624 (synth)Google Scholar
  281. Krumwiede, H.A.,.1. Am. Pharm. Assoc., 1919, 8, 795 (synth, pharmacol)Google Scholar
  282. Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th Ed., Akademie-Verlag, Berlin, 1987, 2728 (synonyms) Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 15301.Google Scholar
  283. Ishida, N. et al, J. Antibiot., 1965, 18, 68; 1966, 19, 253 (isol, props)Google Scholar
  284. Kumagai, K. et al, Antimicrob. Agents Chemother., 1966, 546.Google Scholar
  285. Meienhofer, J. et al, Science, 1972, 178, 875 (struct)Google Scholar
  286. Sieker, L.C. et al, Biochem. Biophys. Res. Commun., 1976, 68Google Scholar
  287. ; Diss. Abstr. Int. B, 1981, 42, 1283.Google Scholar
  288. Kappen, L.S. et al, Biochemistry, 1979, 18, 5123 (props)Google Scholar
  289. Napier, M.A. et al, Biochem. Biophys. Res. Commun., 1979, 89, 635 (props)Google Scholar
  290. Japan. Pat., 79 36 202, (1979); CA, 73136 (isol)Google Scholar
  291. Koehnlein, W. et al, Arzneim.-Forsch., 1982, 32, 1474 (rev, props)Google Scholar
  292. Koide, Y. et al, J. Antibiot., 1982, 35, 766.CrossRefGoogle Scholar
  293. Pletner, V.Z. et al, Bioorg. Khim., 1982, 8, 169 (uv, cd)Google Scholar
  294. Samy, T.S.A. et al, J. Biol. Chem, 1983, 258, 183 (struct)Google Scholar
  295. Edo, K. et al, Tetrahedron Lett., 1985, 26, 331 (struct)Google Scholar
  296. Edo, K. et a!, J. Antibiot., 1986, 39, 1615 (abs config) Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 1881.Google Scholar
  297. Sax, N.I., Dangerous Properties of Industrial Materials, 6th Ed., Van Nostrand-Reinhold, 1984, 1983.Google Scholar
  298. Ford, J.H. et al, J. Am. Chem. Soc., 1955, 77, 5311 (isol)Google Scholar
  299. Rinehart, K.L. et al, J. Am. Chem. Soc., 1957, 79, 4567, 4568; 1958, 80, 6461, 6463 (struct)Google Scholar
  300. Haskell, T.H. et al, J. Org. Chem., 1963, 28, 2598 (struct)Google Scholar
  301. Hichens, M. et al, J. Am. Chem. Soc., 1963, 85, 1547 (struct)Google Scholar
  302. Perlman, D. et al, J. Antibiot., 1974, 27, 637 (deriv)Google Scholar
  303. Heyes, W.F., Anal. Profiles Drug Subst., 1979, 8, 399 (rev)Google Scholar
  304. Chernyshev, A.I. et al, Khim. Prir. Soedin., 1980, 686 (cmr)Google Scholar
  305. Lin, Z.-L. et al, CA, 1981, 95, 220241.Google Scholar
  306. Botto, R.E. et al, J. Am. Chem. Soc., 1983, 105, 1021 (N-15 nmr)Google Scholar
  307. Ewad, M.J.S. et al, J. Chem. Soc., Chem. Commun., 1983, 18, 20 (biosynth)Google Scholar
  308. Usui, T. et al, Carbohydr. Res., 1984, 130, 165 (synth)Google Scholar
  309. Reid, D.G. et al, J. Biol. Chem, 1987, 262, 7967 (pmr, cmr)Google Scholar
  310. Usui, T. et al, J. Antibiot., 1987, 40, 1464 (synth)Google Scholar
  311. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 86, 111, 112, 113. Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th Ed., Akademie-Verlag, Berlin, 1987, 7030.Google Scholar
  312. Sax, N.I., Dangerous Properties of Industrial Materials, 6th Ed., Van Nostrand-Reinhold, 1984, 1985.Google Scholar
  313. Ford, J.H. et al, J. Am. Chem. Soc., 1955, 77, 5311 (iso!)Google Scholar
  314. Rinehart, K.L. et al, J. Am. Chem. Soc., 1957, 79, 4568, 4667; 1958, 80, 6461, 6463; 1962, 84, 3218 (struct)Google Scholar
  315. Hichens, M. et al, J. Am. Chem. Soc., 1963, 85, 1547 (struct)Google Scholar
  316. Umezawa, S. et al, Bull. Chem. Soc. Jpn., 1980, 53, 3259 (synth, bibi)Google Scholar
  317. Ewad, M.J.S. et al, J. Chem. Soc., Chem. Commun., 1983, 18, 20 (biosynth)Google Scholar
  318. U.S.P., 1 905 990, (1933); CA, 27, 3560 (synth)Google Scholar
  319. Petcher, T.J. et al, J. Med. Chem., 1971, 14, 1 (cryst struct)Google Scholar
  320. Calvey, T.N. et al, Br. J. Clin. Pharmacol., 1979, 7, 149 (pharmacol)Google Scholar
  321. Al-Badr, A.A. et al, Anal. Profiles Drug Subst., 1987, 16, 403 (rev, synth, props, anal)Google Scholar
  322. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 4501, 4502.Google Scholar
  323. Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th Ed., Akademie-Verlag, Berlin, 1987, 2555 (synonyms) Sax, N.I., Dangerous Properties of Industrial Materials, 6th Ed., Van Nostrand-Reinhold, 1984, 1144.Google Scholar
  324. Kosuge, T. et al, Tetrahedron Lett., 1981, 3417 (cryst struct)Google Scholar
  325. Kosuge, T. et al, Chem. Pharm. Bull., 1982, 30, 3255 (iso!)Google Scholar
  326. Inoue, S. et al, CA, 1983, 100, 191639 (synth)Google Scholar
  327. Hayashi, E. et al, J. Neurochem., 1984, 42, 1491 (props)Google Scholar
  328. Inoue, S. et al, Tetrahedron Lett., 1986, 27, 5225 (synth)Google Scholar
  329. Takeuchi, T. et al, J. Antibiot., 1976, 29, 93 (isol, nmr, ir, uv, ms)Google Scholar
  330. Miyamoto, M. et al, J. Antibiot., 1977, 30, 340 (synth, struct, uv, pmr, cmr)Google Scholar
  331. Ger. Pat., 2 645 528, (1977); CA, 87, 51624 (manuj)Google Scholar
  332. Fujita, H. et al, J. Antibiot., 1982, 35, 1093 (props)Google Scholar
  333. Tanaka, N., Antibiotics (N.Y.), 1983, 6, 136 (rev)Google Scholar
  334. Andriamialisoa, R.Z. et al, Tetrahedron Lett., 1986, 841 (synth)Google Scholar
  335. Mori, M. et al, J. Chem. Soc., Chem. Commun., 1986, 841 (synth)Google Scholar
  336. Sax, N.I., Dangerous Properties of Industrial Materials, 6th Ed., Van Nostrand-Reinhold, 1984, 1988.Google Scholar
  337. Hashimoto, Y. et al, Ann. N.Y. Acad. Sci., 1960, 90, 669 (isol)Google Scholar
  338. Okaichi, T. et al, Agric. Biol. Chem., 1962, 26, 224 (struct, pmr, pharmacol)Google Scholar
  339. Konishi, K., Agric. Biol. Chem., 1970, 34, 926, 935, 1549 (synth, pmr, uv)Google Scholar
  340. Hashimoto, Y. et al, Food-Drugs Sea, Proc. Conf., 3rd, 1972, 129 (rev, bibi)Google Scholar
  341. Satelle, D.B.,Crop. Prot. Agents-Their Biol. Eval., Proc. Int. Conf., 1975, 421 (pharmacol)Google Scholar
  342. Ger. Pat., 3 005 287, (1981); CA, 95, 169204s (synth, pharmacol)Google Scholar
  343. Belg. Pat., 892 516, (1982); CA, 98, 53874 (synth, pmr, ir)Google Scholar
  344. Scuri, R. et al, Drugs Exp. Clin. Res., 1986, 12, 663 (pharmacol)Google Scholar
  345. Luini, W. et al, Int. J. Immunopharmacol., 1988, 10, 59 (pharmacol)Google Scholar
  346. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 19564.Google Scholar
  347. U.S.P., 4 002 742, (1974); CA, 87, 6298 (synth) Watanakunakorn, C., Antimicrob. Agents Chemother., 1976, 10, 382 (props)Google Scholar
  348. Wright, J.J., J. Chem. Soc., Chem. Commun., 1976, 206 (ms, nmr, synth)Google Scholar
  349. Anon., Drugs of Today, 1981, 17, 322 (rev)Google Scholar
  350. Boxler, D.L. et al, J. Chem. Soc., Perkin Trans. 1, 1981, 2168 (synth)Google Scholar
  351. Nagabhushan, T.L. et al, Carbohydr. Res., 1984, 130, 243 (synth)Google Scholar
  352. Noone, P., Drugs, 1984, 27, 548 (rev)Google Scholar
  353. Solberg, C.O. et al, Netilmicin, Academic Press, London, 1984 (book)Google Scholar
  354. Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th Ed., Akademie-Verlag, Berlin, 1987, 6408.Google Scholar
  355. U.S.P., 4 406 893, (1983); CA, 100, 34285v (synth)Google Scholar
  356. Delatour, P. et al, J. Vet. Pharmacol. Ther., 1986, 9, 230 (pharmacol)Google Scholar
  357. Richards, L.S. et al, Vet. Parasitol., 1987, 26, 71, 79 (pharmacol)Google Scholar
  358. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 2190.Google Scholar
  359. Kitagawa, K. et al, Chem. Pharm. Bull., 1976, 24, 2692 (synth)Google Scholar
  360. Leeman, S.E. et al, Pept. Neurobiol., 1977, 99 (rev)Google Scholar
  361. Bisette, G. et al, Life Sci., 1978, 23, 2173 (rev)Google Scholar
  362. Carraway, R. et al, J. Biol. Chem., 1978, 253, 7996 (struct)Google Scholar
  363. Fukuda, T. et al, J. Chem. Soc., Chem. Commun., 1978, 220 (synth)Google Scholar
  364. Lefemine, D.V. et al, Antimicrob. Agents Chemother., 1963, 41, 134 (isol)Google Scholar
  365. Kunstmann, M.P. et al, Experientia, 196521, 372 (struct)Google Scholar
  366. Omura, S. et al, J. Am. Chem. Soc., 1975, 97, 4001(cmr)Google Scholar
  367. Jardim, M.E. et al, Int. J. Mass Spectrom. Ion Phys., 1983, 48, 189 (ms)Google Scholar
  368. Delahunt, C.S. et al, Toxicol. Appl. Pharmacol., 1959, 1, 523 (tox)Google Scholar
  369. Rowe, R.P. et al, Proc. Soc. Exp. Biol. Med., 1959, 101, 832 (pharmacol)Google Scholar
  370. U.S.P., 2 894 972, (1959); CA, 54, 581iGoogle Scholar
  371. Mukhina, N.A. et al, CA, 1965, 63, 6964e (synth)Google Scholar
  372. Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th Ed., Akademie-Verlag, Berlin, 1987, 3996 (synonyms) Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 2528.Google Scholar
  373. Ger. Pat., 1 957 371, (1970); CA, 73, 25518v (synth, tox, pharmacol)Google Scholar
  374. Duchene-Marullaz, P. et al, Therapie, 1971, 26, 1203 (pharmacol)Google Scholar
  375. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 13006.Google Scholar
  376. Ger. Pat., 2 656 852, (1977); CA, 87, 117793y (synth, ir, pharmacol)Google Scholar
  377. Vezin, J.C. et al, Arzneim.-Forsch., 1979, 29, 1659 (synth, pharmacol)Google Scholar
  378. Ger. Pat., 2 934 609, (1981); CA, 94, 208726q (synth)Google Scholar
  379. Citrate (1:1): [2572–63–6]. Euclidan. Nutrin. Soclidan. Nicametate citrate, JAN. Mp 123–125°.Google Scholar
  380. Blicke, F.F. et al, J. Am. Chem. Soc., 1942, 64, 1722 (synth)Google Scholar
  381. Roux, G. et al, Therapie, 1961, 16, 265 (pharmacol)Google Scholar
  382. Zawisza, T. et al, Pol. J. Pharmacol. Pharm., 1973, 25, 447 (synth)Google Scholar
  383. Seki, K. et al, Chem. Pharm. Bull., 1983, 31, 4116 (synth)Google Scholar
  384. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 9257.Google Scholar
  385. Cerebral vasodilator. Antithrombotic agent. Used to treat brain oedema. Cryst. (EtOAc). Mp 156–157°.Google Scholar
  386. Eur. Pat., 29 602, (1981); CA, 95, 168999 (synth, pharmacol)Google Scholar
  387. Asano, T. et al, Neurol. Res., 1984, 6, 49 (pharmacol)Google Scholar
  388. Koide, T., Bioelectrochem. Bioenerg., 1987, 18, 307 (rev)Google Scholar
  389. Nawata, Y. et al, Acta Crystallogr., Sect. C, 1987, 43, 2249 (cryst struct)Google Scholar
  390. Vasodilator, antihypertensive agent, calcium antagonist. Pale-yellow needles (isopropyl ether). Mp 76–78°. Used mainly as hydrochloride.Google Scholar
  391. Takenaka, T. et al, Arzneim.-Forsch., 1976, 26, 2172 (pharmacol)Google Scholar
  392. Iwanami, M. et al, Chem. Pharm. Bull., 1979, 27, 1426 (synth)Google Scholar
  393. Ohno, S. et al, Chem. Pharm. Bull., 1986, 34, 1589 (synth, pharmacol)Google Scholar
  394. Sorkin, E.M. et al, Drugs, 1987, 33, 296 (rev, pharmacol) Hasegawa, G.R., Clin. Pharm., 1988, 7, 97 (rev)Google Scholar
  395. Negwer, M., Organic-Chemical Drugs and their Synonyms, 6thGoogle Scholar
  396. Ed., Akademie-Verlag, Berlin, 1987, 7413 (synonyms) Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 13008.Google Scholar
  397. Arcari, G. et al, Experientia, 1972, 28, 819.CrossRefGoogle Scholar
  398. Bernardi, L. et al, Farmaco, Ed. Sci., 1975, 30, 789 (synth, pharmacol)Google Scholar
  399. Neumann, B.W. et al, Arzneim.-Forsch., 1979, 29, 1206 (numerous papers)Google Scholar
  400. Shintomi, K. et al, J. Pharmacobio-Dyn., 1987, 10, 35 (pharmacol, tox)Google Scholar
  401. Negwer, M., Organic-Chemical Drugs and their Synonyms, 6thGoogle Scholar
  402. Ed., Akademie-Verlag, Berlin, 1987, 7056 (synonyms) Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 1514.Google Scholar
  403. B.P., 1 053 689, (1967); CA, 66, 104907e (synth)Google Scholar
  404. Brattsand, R. et al, Arzneim.-Forsch., 1971, 21, 1335 (metab)Google Scholar
  405. Brattsand, R. et al, Acta Pharmacol. Toxicol., 1975, 36, 203 (pharmacol)Google Scholar
  406. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 9258.Google Scholar
  407. U.S.P., 3 082 151, (1963); CA, 59, 2599 (synth, pharmacol)Google Scholar
  408. Lane, P.J. et al, Vet. Rec., 1967, 80, 702 (props)Google Scholar
  409. Boersema, J.H., CA, 1975, 82, 80171 (rev)Google Scholar
  410. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 13009.Google Scholar
  411. Bekhli, A.F. et al, Med. Prom. SSSR, 1965, 19, 25; CA, 63, 17959 (synth)Google Scholar
  412. Weuffen, W. et al, Pharmazie, 1968, 23, 308 (pharmacol)Google Scholar
  413. Kosheleva, L.I. et al, Zh. Obshch. Khim., 1975, 45, 407 (ir)Google Scholar
  414. Dubey, S.K. et al, J. Med. Chem., 1978, 21, 1178 (synth, pharmacol)Google Scholar
  415. Andrews, P. et al, Pharmacol. Ther., 1983, 19, 245 (rev, pharmacol)Google Scholar
  416. Owen, J.T.R. et al, J. Assoc. Off. Anal. Chem., 1983, 66, 161 (cryst struct)Google Scholar
  417. Negwer, M., Organic-Chemical Drugs and their Synonyms, 6thGoogle Scholar
  418. Ed., Akademie-Verlag, Berlin, 1987, 2622 (synonyms) Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 793.Google Scholar
  419. Fr. Pat., M3454, (1965); CA, 65, 13667a (synth, pharmacol)Google Scholar
  420. Nordmann, J. et al, Gazz. Med. Ital., 1976, 135, 735; 1977, 136, 11 (pharmacol, tox)Google Scholar
  421. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 1352.Google Scholar
  422. Boucherle, A. et al, Bull. Soc. Chim. Fr., 1960, 1222 (synth)Google Scholar
  423. Pongratz, A. et al, Monatsh. Chem., 1960, 91, 396 (synth)Google Scholar
  424. Cahen, R. et al, Arch. Int. Pharmacodyn. Ther., 1963, 143, 466 (pharmacol)Google Scholar
  425. Cahen, R. et al, Compt. Rend. Soc. Biol., 1964, 158, 1021 (Nicodicodine)Google Scholar
  426. Cahen, R. et al, C.R. Hebd. Seances Acad. Sci., 1965, 261, 275 (Nicodicodine)Google Scholar
  427. Carlson, L.A. et al, Acta Pharm. Suec., 1972, 9, 405 (synth, pharmacol)Google Scholar
  428. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 1353.Google Scholar
  429. B.P., 1 197 978, (1970); CA, 73, 77559d (synth, pharmacol)Google Scholar
  430. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 9259.Google Scholar
  431. Eur. Pat., 33 432, (1981); CA, 96, 68695t (synth, pharmacol)Google Scholar
  432. Belg. Pat., 658 422, (1965); CA, 64, 4875 (synth, pharmacol)Google Scholar
  433. Irikura, T. et al, Pharmacometrics, 1968, 2, 237 (synth, props)Google Scholar
  434. Kitagawa, H. et al, Chem. Pharm. Bull., 1971, 19, 552 (pharmacol)Google Scholar
  435. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 13011.Google Scholar
  436. B,HCI: [65141–45–9]. Cryst. (EtOH). Mp 132°. B,HNO3: [65141–58–4]. Cryst.Google Scholar
  437. Ger. Pat., 2 714 713, (1977); CA, 88, 22652 (synth, pharmacol)Google Scholar
  438. Taira, N. et al, Clin. Exp. Pharmacol. Physiol., 1979, 6, 301 (pharmacol)Google Scholar
  439. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 16912.Google Scholar
  440. Karrer, P. et al, Helv. Chim. Acta, 1925, 8, 364 (abs config)Google Scholar
  441. Swan, M.L. et al, J. Am. Chem. Soc., 1949, 71, 1341 (uv)Google Scholar
  442. Witkop, B., J. Am. Chem. Soc., 1954, 76, 5597 (ir)Google Scholar
  443. Hellmann, H. et al, Justus Liebigs Ann. Chem., 1964, 672, 97 (synth)Google Scholar
  444. Duffield, A.M. et al, J. Am. Chem. Soc., 1965, 87, 2926 (ms)Google Scholar
  445. Breuer, E. et al, Tetrahedron Lett., 1969, 3595 (synth)Google Scholar
  446. Phillipson, J.D. et al, Phytochemistry, 1975, 14, 2683 (oxide)Google Scholar
  447. Crain, W.O. et al, J. Am. Chem. Soc., 1971, 93, 990 (cmr)Google Scholar
  448. Kim, H.S. et al, Acta Crystallogr., Sect. B, 1971, 27, 1123 (cryst struct, salicylate)Google Scholar
  449. Hutchinson, C.R. et al, J. Am. Chem. Soc., 1976, 98, 6006 (bio-synth)Google Scholar
  450. Whidby, J.F. et al, J. Org. Chem., 1976, 41, 1585 (pmr, config)Google Scholar
  451. Enzell, C.R. et al, Fortschr. Chem. Org. Naturst., 1977, 34, 44 (rev)Google Scholar
  452. Banerjee, A. et al, Life Sci. Adv., 1982, 1, 327 (rev, pharmacol)Google Scholar
  453. Schievelbein, H.,Pharmacol. Ther., 1982, 18, 233 (rev, metab)Google Scholar
  454. Wigle, I.D. et al, J. Chem. Soc., Chem. Commun., 1982, 662 (biosynth)Google Scholar
  455. Aceto, M.D. et al, CRC Handb. Stereoisomers: Drugs Psychopharmacol, 1984, 67 (rev)Google Scholar
  456. Seeman, J.I., Heterocycles, 1984, 22, 165 (rev)Google Scholar
  457. Slaven, R.W., J. Heterocycl. Chem., 1984, 21, 1329 (cmr, pmr)Google Scholar
  458. Domino, E.F., Psychopharmacol. Bull., 1986, 22, 870 (rev, pharmacol)Google Scholar
  459. Kyerematen, G.A. et al, Drug Metab. Dispos., 1988, 16, 125 (pharmacol)Google Scholar
  460. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 15303.Google Scholar
  461. Sax, N.I., Dangerous Properties of Industrial Materials, 6th Ed., Van Nostrand-Reinhold, 1984, 1997.Google Scholar
  462. Fox, S.W. et al, J. Biol. Chem., 1943, 147, 651 (synth)Google Scholar
  463. Rohrlich, M., Arch. Pharm. (Weinheim, Ger.), 1951, 284, 6; CA, 45, 10245c (synth)Google Scholar
  464. Krishnaswamy, S. et al, Acta Crystallogr., Sect. C, 1987, 43, 728 (cryst struct)Google Scholar
  465. U.S.P., 2 648 682, (1953); CA, 49, 2522g (synth)Google Scholar
  466. Jindal, M.N. et al, Arzneim.-Forsch., 1966, 16, 878 (pharmacol)Google Scholar
  467. Wheeler, C.R. et al, J. Med. Chem., 1979, 22, 1122 (abs config, resoln)Google Scholar
  468. Godbillon, J. et al, Br. J. Clin. Pharmacol., 1981, 12, 621 (pharmacol, isom)Google Scholar
  469. Thijssen, H.H.W. et al, Drug Metab. Dispos., 1985, 13, 593 (metab)Google Scholar
  470. Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th Ed., Akademie-Verlag, Berlin, 1987, 5111 (synonyms) Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 4817.Google Scholar
  471. Belg. Pat., 900 192, (1984); CA, 102, 113539 (synth)Google Scholar
  472. Cargnelli, G. et al, Eur. J. Pharmacol., 1987, 136, 163 (pharmacol)Google Scholar
  473. Colot, M. et al, Therapie, 1973, 28, 775 (pharmacol)Google Scholar
  474. Descamps, M. et al, Chim. Ther., 1973, 8, 173 (synth, pharmacol)Google Scholar
  475. Rosseels, G. et al, Bull. Soc. Chim. Belg., 1975, 84, 263 (synth)Google Scholar
  476. Bergman, J. et al, Heterocycles,.1982, 19, 297 (synth)Google Scholar
  477. Kashiwara, M. et al, J. Chem. Soc. Jpn., 1952, 55, 593 (synth)Google Scholar
  478. Hayes, K. et al, J. Am. Chem. Soc., 1955, 77, 2282 (synth)Google Scholar
  479. Ger. Pat., 974 710, (1961); CA, 57, 7233c (synth)Google Scholar
  480. B.P., 1 604 850, (1979); CA, 91, 57548t (synth, pharmacol)Google Scholar
  481. Morgan, D.R. et al, Infect. Immun., 1985, 48, 754 (pharmacol)Google Scholar
  482. Ryan, J. et al, Clin. Pharmacol. Ther., 1986, 39, 40(pharmacol)Google Scholar
  483. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 19568.Google Scholar
  484. Vater, W. et al, Arzneim.-Forsch., 1972, 22, 1, 15, 330 (pharmacol)Google Scholar
  485. Loev, B. et al, J. Med. Chem., 1974, 17, 956 (synth)Google Scholar
  486. Bossert, F. et al, Angew. Chem., Int. Ed. Engl., 1981, 20, 762 (rev)Google Scholar
  487. Kurfurst, A. et al, Collect. Czech. Chem. Commun., 1984, 49, 2393 (pmr, cmr)Google Scholar
  488. Pine, R.M. et al, Clin. Ther., 1984, 6, 245 (rev)Google Scholar
  489. Hugenholz, P.G., Handb. Exp. Pharmacol., 1985, 76, 459 (rev)Google Scholar
  490. Krebs, R.,Ed., Treatment of Cardiovascular Diseases by Adalet (Nifedipine), Schatteur, Stuttgart, Ger., 1986 (book)Google Scholar
  491. Swanson, T.H. et al, Gen. Pharmacol., 1986, 17, 255 (rev) Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th Ed., Akademie-Verlag, Berlin, 1987, 4359 (synonyms) Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 9263.Google Scholar
  492. Teotino, U.M. et al, Farmaco, Ed. Sci., 1962, 17, 252 (synth)Google Scholar
  493. Somani, P. et al, J. Pharmacol. Exp. Ther., 1965, 147, 194 (pharmacol)Google Scholar
  494. Almirante, L. et al, J. Med. Chem., 1966, 9, 650 (isomers)Google Scholar
  495. Balsamo, A. et al, Eur. J. Med. Chem.-Chim. Ther., 1982, 17, 471 (nmr)Google Scholar
  496. Lindner, W. et al, J. Chromatogr., 1984, 316, 605 (resoln, hplc)Google Scholar
  497. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 6316.Google Scholar
  498. Pongratz, A. et al, Monatsh. Chem., 1957, 88, 330 (synth)Google Scholar
  499. Zorn, B. et al, Pharmazie, 1957, 12, 396 (synth, pharmacol)Google Scholar
  500. Klosa, J., J. Prakt. Chem., 1966, 31, 41 (synth)Google Scholar
  501. Katsnel’son, M.G. et al, CA, 1967, 66, 75952 (synth)Google Scholar
  502. Okada, J. et al, Chem. Pharm. Bull., 1976, 24, 61 (cmr)Google Scholar
  503. Beyer, K.H. et al, Arch. Pharm. (Weinheim, Ger.), 1985, 318, 855 (metab)Google Scholar
  504. Marciniec, B., Pharmazie, 1985, 40, 110 (ms)Google Scholar
  505. Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th Ed., Akademie-Verlag, Berlin, 1987, 4304 (synonyms) Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 2676.Google Scholar
  506. Hoffmann, C. et al, Bull. Soc. Chim. Fr., 1966, 2316 (synth)Google Scholar
  507. Glasson, B. et al, Biochem. Pharmacol., 1969, 18, 633 (pharmacol, metab)Google Scholar
  508. Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th Ed., Akademie-Verlag, Berlin, 1987, 2640 (synonyms) Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 2677.Google Scholar
  509. U.S.P., 3 989 840, (1976); CA, 86, 84756 (synth, props)Google Scholar
  510. Boisvenue, R.J. et al, Experientia, 1980, 36, 189 (props)Google Scholar
  511. West, S.D. et al, J. Assoc. Off. Anal. Chem., 1983, 66, 111(hplc)Google Scholar
  512. Michels, J.G. et al, J. Am. Chem. Soc., 1956, 78, 5349 (synth)Google Scholar
  513. Ronald, A.R. et al, Antimicrob. Agents Chemother., 1967, 506 (props)Google Scholar
  514. Snyder, H.R. et al, J. Med. Chem., 1970, 13, 756; 1975, 18, 524 (demo, pharmacol)Google Scholar
  515. Pugh, D.L. et al, J. Med. Chem., 1972, 15, 270 (metab)Google Scholar
  516. Ger. Pat., 974 710, (1961); CA, 57, 7233c (synth, pharmacol)Google Scholar
  517. Ger. Pat., 2 500 490t, (1975); CA, 83, 193293t (synth, pharmacol)Google Scholar
  518. Belg. Pat., 635 608, (1963); CA, 61, 16069 (synth)Google Scholar
  519. Scuri, R. et al, Farmaco, Ed. Sci., 1964, 19, 301 (pharmacol)Google Scholar
  520. Fr. Pat., M 4 544, (1966); CA, 69, 59221 (synth, pharmacol)Google Scholar
  521. Friberger, P. et al, Arzneim.-Forsch., 1970, 20, 1945 (metab)Google Scholar
  522. Wildfever, A., Arzneim.-Forsch., 1974, 24, 937 (use)Google Scholar
  523. Hamilton-Miller, J.M.T. et al, Chemotherapy (Basel), 1978, 24, 161 (use)Google Scholar
  524. Pitzus, E. et al, J. Int. Med. Res., 1978, 6, 414 (use)Google Scholar
  525. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 4789.Google Scholar
  526. B.P., 1 105 007, (1968); CA, 69, 86809e (synth, pharmacol)Google Scholar
  527. Ritter, H.W. et al, Antimicrob. Agents Chemother., 1970, 254, 260 (pharmacol)Google Scholar
  528. Kliegel, W. et al, Chem. Ber., 1983, 116, 27 (synth)Google Scholar
  529. Ebetino, F.F., J. Org. Chem., 1964, 29, 2582 (synth)Google Scholar
  530. Buzard, J.A. et al, Br. J. Pharmacol., 1965, 24, 266 (pharmacol)Google Scholar
  531. Wang, T.S., Appl. Spectrosc., 1968, 22, 167 (ir)Google Scholar
  532. E. Ger. Pat., 50 615, (1966); CA, 66, 65501w (synth, pharmacol)Google Scholar
  533. Snyder, H.R. et al, J. Med. Chem., 1975, 18, 942 (synth, pharmacol)Google Scholar
  534. Ger. Pat., 1 932 844, (1970); CA, 72, 90493b (synth, pharmacol)Google Scholar
  535. Fr. Pat., 1 489 091, (1967); CA, 69, 19154z (synth, pharmacol)Google Scholar
  536. Vindel, J. et al, C.R. Hebd. Seances Acad. Sci., Ser. D, 1970, 270, 2512 (pharmacol)Google Scholar
  537. Tekeli, S. et al, Cancer Res., 1973, 33, 2894 (tox)Google Scholar
  538. Ger. Pat., 2 612 250, (1977); CA, 86, 39881g (synth, pharmacol)Google Scholar
  539. U.S.P., 4 217 456, (1980); CA, 94, 139636 (synth, pharmacol)Google Scholar
  540. Carron, M. et al, Ann. Pharm. Fr., 1963, 61, 287 (synth, pharmacol)Google Scholar
  541. Gustowski, W. et al, Rocz. Chem., 1963, 37, 437 (synth)Google Scholar
  542. El-Obeid, H.A. et al, Pharm. Res., 1985, 42 (synth, props)Google Scholar
  543. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 13014.Google Scholar
  544. Massarani, E. et al, Experientia, 1971, 27, 1243 (synth, pharmacol)Google Scholar
  545. Degen, L. et al, Chemotherapy (Basel), 1972, 18, 85 (pharmacol)Google Scholar
  546. Fontani, F. et al, Farmaco, Ed. Prat., 1973, 28, 547 (props)Google Scholar
  547. Setnikar, I. et al, Boll. Chim. Farm., 1975, 114, 73 (tox)Google Scholar
  548. Fujita, A. et al, J. Pharm. Soc. Jpn., 1966, 86, 1014 (synth)Google Scholar
  549. Takase, Y. et al, Chem. Pharm. Bull., 1973, 21, 144 (pharmacol)Google Scholar
  550. Belg. Pat., 630 163, (1963); CA, 60, 14516a (synth, pharmacol)Google Scholar
  551. Burch, H.A., J. Med. Chem., 1966, 9, 408 (synth, pharmacol)Google Scholar
  552. Geyer, G. et al, J. Org. Chem., 1949, 14, 813 (synth)Google Scholar
  553. Kawabe, K. et al, Yakugaku Zasshi, 1960, 80, 65; CA, 54, 12091i (synth)Google Scholar
  554. U.S.P., 3 253 987, (1966); CA, 65, 4332 (pharmacol)Google Scholar
  555. Berndt, E.W. et al, J. Med. Chem., 1969, 12, 371 (synth, pharmacol)Google Scholar
  556. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 13015.Google Scholar
  557. Holper, J.C. et al, Antimicrob. Agents Chemother., 1962, 268 (pharmacol)Google Scholar
  558. Sherman, W.R. et al, J. Org. Chem., 1962, 27, 1351 (synth)Google Scholar
  559. Cohen, S.M. et al, Cancer Res., 1973, 33, 2802 (metab)Google Scholar
  560. Bock, M. et al, Arzneim.-Forsch., 1972, 22, 1563 (synth, pharmacol)Google Scholar
  561. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 4790.Google Scholar
  562. Akio, F. et al, Chem. Pharm. Bull., 1965, 13, 1183 (synth, pharmacol)Google Scholar
  563. Katae, H. et al, Arzneim.-Forsch., 1967, 17, 1030 (props)Google Scholar
  564. Nakamura, S. et al, Chem. Pharm. Bull., 1973, 21, 137 (props)Google Scholar
  565. Szarvasi, E. et al, J. Med. Chem., 1973, 16, 281 (synth, pharmacol)Google Scholar
  566. Videz, S. et al, Ann. Pharm. Fr., 1981, 39, 451 (pharmacol)Google Scholar
  567. Spencer, C.F. et al, J. Org. Chem., 1964, 29, 3416 (synth, ir, nmr)Google Scholar
  568. English, A.R. et al, Antimicrob. Agents Chemother., 1966, 434 (pharmacol)Google Scholar
  569. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 13016.Google Scholar
  570. Eur. Pat., 176 956, (1986); CA, 105, 35619x (synth, pharmacol)Google Scholar
  571. Eur. Pat., 240 828, (1987); CA, 108, 112246q (synth, isomers, pharmacol)Google Scholar
  572. Ger. Pat., 3 709 796, (1987); CA, 108, 112247r (synth, pharmacol)Google Scholar
  573. Ger. Pat., 974 710, (1961); CA, 57, 7233i (synth, pharmacol)Google Scholar
  574. Olivard, J. et al, J. Med. Chem., 1962, 5, 524 (metab)Google Scholar
  575. Antkowiak, J.J. et al, J. Chromatogr., 1967, 29, 277 (tic)Google Scholar
  576. Ger. Pat., 2 753 244, (1979); CA, 91, 91250z (synth, ir)Google Scholar
  577. Krause, W. et al, Prostaglandins, Leukotrienes Med., 1983, 11, 241 (metab)Google Scholar
  578. Ger. Pat., 2 557 446, (1976); CA, 85, 192729u (synth, pharmacol)Google Scholar
  579. Bossert, F. et al, Arzneim.-Forsch., 1979, 29, 226, 230, 246 (synth, pharmacol)Google Scholar
  580. Hiwatari, M. et al, Arzneim.-Forsch., 1979, 29, 1368, 1373 (pharmacol)Google Scholar
  581. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 16913.Google Scholar
  582. Ger. Pat., 2 649 925, (1977); CA, 87, 85005 (synth)Google Scholar
  583. Raynaud, J.P. et al, Prog. Clin. Biol. Res., 1985, 185A, 99 (rev, pharmacol)Google Scholar
  584. Moguilewsky, M. et al, J. Steroid Biochem., 1987, 27, 871 (rev, pharmacol)Google Scholar
  585. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 2968.Google Scholar
  586. Vasodilator, calcium antagonist. Yellow prisms (EtOH). Mp 148–150°.Google Scholar
  587. Ger. Pat., 2 940 833, (1980); CA, 93, 220594g (synth, pharmacol)Google Scholar
  588. U.S.P., 3 429 911, (1969); CA, 70, 96783b (synth, pharmacol)Google Scholar
  589. Perronnet, J. et al, Bull. Soc. Chim. Fr., 1970, 1168 (synth)Google Scholar
  590. U.S.P., 3 856 859, (1974); CA, 82, 170368m (synth)Google Scholar
  591. Swingle, K.F. et al, Arch. Int. Pharmacodyn. Ther., 1976, 221, 132 (pharmacol)Google Scholar
  592. Swingle, K.F. et al, Drugs Exp. Clin. Res., 1984, 10, 587 (rev)Google Scholar
  593. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 13017.Google Scholar
  594. Sternbach, L.H. et al, J. Med. Chem., 1963, 6, 261 (synth)Google Scholar
  595. Sakai, S. et al, Arzneim.-Forsch., 1972, 22, 534 (pharmacol)Google Scholar
  596. Sarrazin, M. et al, Org. Magn. Reson., 1975, 7, 89 (nmr)Google Scholar
  597. De Silva, J.A.F. et al, Anal. Chem., 1976, 48, 10 (hplc)Google Scholar
  598. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 13018.Google Scholar
  599. U.S.P., 3 842 096, (1973); CA, 82, 43390n (synth, pharmacol)Google Scholar
  600. B.P., 2 018 134, (1979); CA, 92, 220691r (synth, pharmacol)Google Scholar
  601. Meyer, H. et al, Arzneim.-Forsch., 1981, 31, 407; 1983, 33, 106 (synth, pharmacol)Google Scholar
  602. Scriabine, A. et al, Ann. N.Y. Acad. Sci., 1988, 522, 698 (rev, pharmacol)Google Scholar
  603. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 16914.Google Scholar
  604. Giraldi, P.N. et al, Arzneim.-Forsch., 1970, 20, 52 (synth, pharmacol)Google Scholar
  605. Barbiera, P. et al, Boll. Chim. Farm., 1972, 111, 541 (pharmacol)Google Scholar
  606. Caplar, V. et al, Acta Pharm. Jugosl., 1975, 25, 71 (synth)Google Scholar
  607. Nagarajan, K. et al, Indian J. Chem., Sect. B, 1982, 21, 1006 (uv, pmr, ms)Google Scholar
  608. Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th Ed., Akademie-Verlag, Berlin, 1987, 1318 (synonyms) Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 4791.Google Scholar
  609. Ger. Pat., 2 257 360, (1973); CA, 79, 53186c (synth, pharmacol)Google Scholar
  610. Shimizu, F. et al, Gann., 1975, 66, 149 (pharmacol) Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 13019.Google Scholar
  611. Yamamoto, H. et al, Chem. Pharm. Bull., 1968, 16, 1927 (synth, ir, tox, pharmacol)Google Scholar
  612. U.S.P., 3 822 275, (1974); CA, 82, 125272 (synth, pharmacol)Google Scholar
  613. Pakula, R. et al, Sci. Pharm., 1985, 53, 139 (synth)Google Scholar
  614. Belg. Pat., 894 093, (1982); CA, 98, 107277 (synth, pharmacol)Google Scholar
  615. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 2874.Google Scholar
  616. Asada, H. et al, J. Pharmacol. Exp. Ther., 1982, 223, 560 (pharmacol)Google Scholar
  617. Uchida, Y. et al, Arch. Mt. Pharmacodyn. Ther., 1983, 262, 132 (pharmacol)Google Scholar
  618. Yoneda, M. et al, Chem. Pharm. Bull., 1985, 33, 2735 (absconfig, resoln)Google Scholar
  619. Shiratsuchi, M. et al, Chem. Pharm. Bull., 1987, 35, 632, 3691 (synth, pharmacol, bib!)Google Scholar
  620. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 19579.Google Scholar
  621. Tubaro, E. et al, Arzneim.-Forsch., 1970, 20, 1019, 1024 (pharmacol)Google Scholar
  622. Banci, F. et al, Arzneim.-Forsch., 1971, 21, 1665 (synth, pharmacol)Google Scholar
  623. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 13020.Google Scholar
  624. Lambert, C.R. et al, Experientia, 1964, 20, 452 (synth)Google Scholar
  625. Schmidt, P. et al, Angew. Chem., Int. Ed. Engl., 1966, 5, 857.Google Scholar
  626. Wilhelm, M. et al, Heiv. Chim. Acta, 1966, 49, 2443.Google Scholar
  627. Archer, S. et al, Fortschr. Arzneimittelforsch., 1972, 16, 11 (rev)Google Scholar
  628. Kutter, E. et al, Arzneim.-Forsch., 1972, 22, 1045 (synth, pharmacol)Google Scholar
  629. Peeters, O.M. et al, Acta Crystallogr., Sect. C, 1984, 40, 1748 (cryst struct)Google Scholar
  630. Valencia, C.I. et al, J. Pharmacol. Exp. Ther., 1984, 230, 133 (metab)Google Scholar
  631. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 794.Google Scholar
  632. Sax, N.I., Dangerous Properties of Industrial Materials, 5th Ed., Van Nostrand-Reinhold, 1979, 853.Google Scholar
  633. U.S.P., 3 904 671, (1975); CA, 84, 16943e (synth, pharmacol)Google Scholar
  634. Tullar, B.F. et al, J. Med. Chem., 1976, 19, 834 (synth, pharmacol)Google Scholar
  635. Tranquilliser, sedative, hypnotic. Mp 89–90°.Google Scholar
  636. Ludwig, B.J. et al, J. Med. Chem., 1969, 12, 462 (synth, pharmacol)Google Scholar
  637. Ger. Pat., 2 549 568, (1977); CA, 87, 84831d (synth, pharmacol)Google Scholar
  638. Kazda, S. et al, Arzneim.-Forsch., 1980, 30, 2144 (pharmacol)Google Scholar
  639. Kazda, S. et al, New Drugs Annu: Cardiovasc. Drugs, 1983, 1, 243 (rev)Google Scholar
  640. Hugenholtz, P.G. et al, (Eds.) Nisoldipine 1987, Springer-Verlag, Berlin, 1987 (book)Google Scholar
  641. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 13022.Google Scholar
  642. Wong, D.T. et al, Life Sci., 1975, 17, 755 (pharmacol)Google Scholar
  643. U.S.P., 4 018 895, (1977); CA, 87, 134520z (synth, pharmacol)Google Scholar
  644. Hirsch, A.F. et al, J. Med. Chem., 1977, 20, 1546 (synth, pharmacol)Google Scholar
  645. Patrick, J.E. et al, Steroids, 1978, 32, 147 (metab)Google Scholar
  646. Cavier, R. et al, Eur. J. Med. Chem.-Chim. Ther., 1978, 13, 539 (synth, pharmacol)Google Scholar
  647. Murphy, J.R. et al, J. Appl. Toxicol., 1985, 5, 49 (tox)Google Scholar
  648. Fr. Pat., 1 458 183, (1966); CA, 68, 39493s (synth, pharmacol)Google Scholar
  649. Gieldanowski, J. et al, Arch. Immunol. Ther. Exp., 1972, 20, 399 (pharmacol, tox)Google Scholar
  650. U.S.P., 3 989 835, (1976); CA, 86, 72644 (synth, pharmacol)Google Scholar
  651. Ger. Pat., 2 459 090, (1975); CA, 83, 114468c (synth, pharmacol)Google Scholar
  652. Glaser, T. et al, Agents Actions, 1984, 15, 341 (pharmacol)Google Scholar
  653. Tweit, R.C. et al, J. Med. Chem., 1965, 8, 374 (synth, pharmacol)Google Scholar
  654. Ibragimov, A.A. et al, Khim. Prir. Soedin., 1975, 11, 273, 275, 276;Google Scholar
  655. Chem. Nat. Compd., 295, 298 (isol, uv, ms, pmr, cryst struct, derivs)Google Scholar
  656. Nasirov, S.-M. et al, Khim. Prir. Soedin., 1976, 12, 334 (cryst struct)Google Scholar
  657. Vakhabov, A. et al, CA, 1980, 92, 209116 (rev, pharmacol)Google Scholar
  658. Barlow, L.R. et al, J. Chem. Soc. (A), 1968, 1609 (synth, ir)Google Scholar
  659. Schwartzman, G., J. Pharm. Sci., 1978, 67, 539 (uv, ir)Google Scholar
  660. Sternbach, L.H. et al, J. Med. Chem., 1963, 6, 261.CrossRefGoogle Scholar
  661. Rieder, J. et al, Arzneim.-Forsch., 1973, 23, 212 (metab)Google Scholar
  662. Gilli, G. et al, Acta Crystallogr., Sect. B, 1977, 33, 2664 (cryst struct)Google Scholar
  663. Aboul-Enein, H.Y. et al, Anal. Profiles Drug Subst., 1980, 9, 487 (rev)Google Scholar
  664. Clarke, G.M. et al, J. Chem. Res. (S), 1980, 400 (synth)Google Scholar
  665. Haran, R. et al, J. Heterocycl. Chem., 1980, 17, 1483 (pmr, cmr)Google Scholar
  666. Killam, E.K. et al, Adv. Neurol., 1980, 27, 597 (rev, pharmacol)Google Scholar
  667. Hannoun, M. et al, J. Heterocycl. Chem., 1981, 18, 963 (synth)Google Scholar
  668. Unterhalt, B., Arch. Pharm. (Weinheim, Ger.), 1981, 314, 733(N-15 nmr)Google Scholar
  669. Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th Ed., Akademie-Verlag, Berlin, 1987, 3435 (synonyms) Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 4054.Google Scholar
  670. Meyer, H. et al, Arzneim.-Forsch., 1981, 31, 407 (synth, pharmacol)Google Scholar
  671. Scriabine, A. et al, (Eds.), Nitrendipine, Urban and Schwarzenberg, Baltimore, Md., 1984 (book)Google Scholar
  672. Scriabine, A. et al, New Drugs Annu: Cardiovasc. Drugs, 1984, 2, 37 (rev, pharmacol)Google Scholar
  673. Kuhnert-Brandstaetter, M. et al, Sci. Pharm., 1986, 54, 71 (polymorphism)Google Scholar
  674. Hasegawa, G.R., Clin. Pharm., 1988, 7, 97 (rev)Google Scholar
  675. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 16915.Google Scholar
  676. B.P. 1 408 391, (1975); CA, 79, 18736k (synth)Google Scholar
  677. Montgomery, K. et al, J. Clin. Microbiol., 1979, 9, 205 (use)Google Scholar
  678. Netherlands Pat., 6 507 637, (1965); CA, 64, 15903h (synth, pharmacol)Google Scholar
  679. Fr. Pat., M4206, (1966); CA, 68, 78324g (synth)Google Scholar
  680. Schmitt, J. et al, Eur. J. Med. Chem.-Chim. Ther., 1969, 4, 239 (synth, activity)Google Scholar
  681. Netherlands Pat., 04 839, (1971); CA, 78, 58021 j (synth, pharmacol)Google Scholar
  682. Petisi, J. et al, J. Med. Chem., 1962, 5, 538 (synth, pharmacol)Google Scholar
  683. Miller, G.H. et al, J. Pharm. Sci., 1971, 60, 33 (synth, pharmacol)Google Scholar
  684. U.S.P., 2 952 673, (1960); CA, 55, 4534c (synth, pharmacol)Google Scholar
  685. McGuire, W.C. et al, J. Parasitol., 1966, 52, 528 (pharmacol)Google Scholar
  686. Leland, S.E. et al, J. Parasitol., 1967, 53, 20 (pharmacol)Google Scholar
  687. Cryst. (pet. ether). Mod. sol. H2O. Mp 35–36°. Bp10 128132°. Extensively hydrated in aq. soln.Google Scholar
  688. Gilman, H. et al, J. Am. Chem. Soc., 1930, 52, 2552 (synth)Google Scholar
  689. U.S.P., 2 319 481, (1943); CA, 37, 6413 (Nifuroxime)Google Scholar
  690. Raffauf, R.F. et al, J. Am. Chem. Soc., 1946, 68, 1765 (uv)Google Scholar
  691. U.S.P., 2 416 234, (1947); CA, 41, 3488 (Nitrofurazone)Google Scholar
  692. U.S.P., 2 927 110, (1960); CA, 54, 12158 (Nitrofurazone)Google Scholar
  693. Howarth, G.A. et al, Talanta, 1969, 16, 967 (Nifuroxime)Google Scholar
  694. Chamberlain, R.E., J. Antimicrob. Chemother., 1976, 2, 325 (Nitrofurazone, rev)Google Scholar
  695. Csaszar, J., Acta Phys. Chem., 1984, 30, 71 (Nitrofurazone)Google Scholar
  696. Busker, R.W. et al, Heterocycles, 1987, 26, 5 (props)Google Scholar
  697. Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th Ed., Akademie-Verlag, Berlin, 1987, 417 (Nitrofurazone) Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 1626, 2594.Google Scholar
  698. Sax, N.I., Dangerous Properties of Industrial Materials, 6th Ed., Van Nostrand-Reinhold, 1984, 2019 (Nitrofurazone)Google Scholar
  699. U.S.P., 2 610 181, (1952); CA, 47, 6980i (synth)Google Scholar
  700. Swirska, A. et al, CA, 1958, 52, 14079 (synth)Google Scholar
  701. U.S.P., 2 898 335, (1959); CA, 54, 2356i (synth)Google Scholar
  702. Cadwallader, D.E. et al, Anal. Profiles Drug Subst., 1976, 5, 345 (rev)Google Scholar
  703. Chamberlain, R.E., J. Antimicrob. Chemother., 1976, 2, 325 (pharmacol, rev)Google Scholar
  704. Gleckman, R. et al, Am. J. Hosp. Pharm., 1979, 36, 342 (rev)Google Scholar
  705. Baeva, V. et al, CA, 1983, 98, 125968 (synth)Google Scholar
  706. Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th Ed., Akademie-Verlag, Berlin, 1987, 824 (synonyms) Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 5651, 5652.Google Scholar
  707. Nakamura, S. et al, J. Antibiot. Ser. A, 1955, 8, 66 (isol)Google Scholar
  708. Beaman, A.G. et al, J. Am. Chem. Soc., 1965, 87, 389 (synth)Google Scholar
  709. Nakane, A. et al, J. Biol.Chem., 1977, 252, 5267 (biosynth)Google Scholar
  710. Agrawal, K.C. et al, J. Med. Chem., 1979, 22, 583 (synth)Google Scholar
  711. Luijten, W.C. et al, Org. Mass Spectrom., 1982, 17, 299 (ms)Google Scholar
  712. Nair, M.D. et al, Prog. Drug Res., 1983, 27, 163 (rev, pharmacol)Google Scholar
  713. Larsen, I.K., Acta Crystallogr., Sect. C, 1984, 40, 285 (cryst struct)Google Scholar
  714. Ger. Pat., 1 935 338, (1970); CA, 73, 25110f (synth, pharmacol)Google Scholar
  715. Striebel, H.P., Experientia, 1976, 32, 457 (pharmacol)Google Scholar
  716. Vaidaya, A.B. et al, Br. J. Clin. Pharmacol., 1977, 4, 463 (tox)Google Scholar
  717. Rajappa, S. et al, J. Chem. Soc., Perkin Trans. 1, 1979, 2027 (synth)Google Scholar
  718. Hardgrove, G.L. et al, Acta Crystallogr., Sect. C, 1983, 39, 616 (cryst struct) Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 12371.Google Scholar
  719. U.S.P., 1 544 293, (1925) (synth)Google Scholar
  720. Barr, F.S. et al, J. Pharm. Sci., 1970, 59, 262 (pharmacol)Google Scholar
  721. Honigman, J.L., Pharm. J., 1975, 523 (tox)Google Scholar
  722. Wald, H.A. et al, Nature (London), 1966, 211, 538 (pharmacol, isom)Google Scholar
  723. Fr. Pat., 1 464 253, (1966); CA, 67, 64214v (synth)Google Scholar
  724. Katzenellenbogen, B.S. et al, Endocrinology, 1975, 97, 1 (pharmacol)Google Scholar
  725. Astle, M.J. et al, J. Org. Chem., 1956, 21, 1228 (synth)Google Scholar
  726. Hesse, G. et al, Justus Liebigs Ann. Chem., 1962, 658, 21 (synth)Google Scholar
  727. Clitheroe, A. et al, J. Pharm. Pharmacol., 1965, 17, 167 (pharmacol)Google Scholar
  728. Meyers, A.I. et al, J. Org. Chem., 1967, 32, 4134 (synth, pmr)Google Scholar
  729. Kambe, S. et al, Bull. Chem. Soc. Jpn., 1968, 41, 1444 (synth)Google Scholar
  730. Org. Synth., Coll. Vol., 3, 665 (synth)Google Scholar
  731. Jacobs, W.A. et al, J. Am. Chem. Soc., 1918, 40, 1580 (synth)Google Scholar
  732. McGregor, J.K. et al, Poultry Sci., 1964, 43, 1026 (pharmacol)Google Scholar
  733. Modro, T.A. et al, Tetrahedron, 1972, 28, 3867 (uv)Google Scholar
  734. Zakirov, D.U., lzu. Akad. Nauk SSSR, Ser. Khim., 1977, 910 (nqr)Google Scholar
  735. Ambushev, F.D. et al, Zh. Obshch. Khim., 1981, 51, 2232 (synth)Google Scholar
  736. Kosolapoff, G.M., J. Am. Chem. Soc., 1949, 71, 1876 (ester)Google Scholar
  737. Kagan, F. et al, J. Am. Chem. Soc., 1959, 81, 3026 (synth, props)Google Scholar
  738. Inglot, A.D. et al, Nature (London), 1965, 207, 784CrossRefGoogle Scholar
  739. Scherer, H. et al, Chem. Ber., 1972, 105, 3357 (ester, ir, pmr)Google Scholar
  740. Williams, A. et al, J. Chem. Soc., Perkin Trans. 2, 1973, 25 (synth)Google Scholar
  741. Ernst, L., Org. Magn. Reson., 1977, 9, 35 (cmr, nmr)Google Scholar
  742. Okamoto, Y. et al, Bull. Chem. Soc. Jpn., 1987, 60, 277 (synth, uv, pmr, P nmr)Google Scholar
  743. Martvou, A. et al, Chem. Zvesti, 1969, 23, 181 (synth, ir, uv)Google Scholar
  744. Gemmell, M.A. et al, Res. Vet. Sci., 1975, 19, 217 (pharmacol)Google Scholar
  745. Boray, J.C. et al, Aust. Vet. J., 1979, 55, 45 (pharmacol) Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 13027.Google Scholar
  746. Gepner, B. et al, J. Gen. Chem. USSR (Engl. Trans!.), 1946, 16, 179; CA, 41, 96 (synth)Google Scholar
  747. Kuznetsov, V.M. et al, CA, 1978, 89, 199883 (hazard)Google Scholar
  748. Liu, K.-C. et al, J. Chin. Chem. Soc. (Taipei), 1978, 25, 77 (synth)Google Scholar
  749. Bretherick, L., Handbook of Reactive Chemical Hazards, 2nd Ed., Butterworths, London and Boston, 1979, 309.Google Scholar
  750. Sax, N.I., Dangerous Properties of Industrial Materials, 5th Ed., Van Nostrand-Reinhold, 1979, 870.Google Scholar
  751. Hazards in the Chemical Laboratory, (Bretherick, L., Ed.), 3rd Ed., Royal Society of Chemistry, London, 1981, 420.Google Scholar
  752. Nitrogen oxide. Dinitrogen monoxide. Laughing gasGoogle Scholar
  753. Jones, K., Compr. Inorg. Chem., 1973, 2, 316 (rev)Google Scholar
  754. Brauer, G., Handbuch Prap. Anorg. Chem., 3rd Ed., 1975–1981, 468 (synth)Google Scholar
  755. Brodsky, J.B. et al, Med. Toxicol., 1986, 1, 362 (tox)Google Scholar
  756. Gillman, M.A., Br. J. Anaesth., 1987, 59, 143 (rev, pharmacol)Google Scholar
  757. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 3119.Google Scholar
  758. Sax, N.I. et al, Dangerous Properties of Industrial Materials, 7th Ed., Van Nostrand-Reinhold, 1989, 2525.Google Scholar
  759. U.S.P. 3 539 556, (1969); CA, 72, 3648q (synth, pharmacol)Google Scholar
  760. U.S.P., 4 382 090, (1983); CA, 99, 43548w (synth, pharmacol)Google Scholar
  761. Price, A.H. et al, Drugs, 1988, 36, 521 (rev)Google Scholar
  762. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 12003.Google Scholar
  763. Fumarate: [93929–95–4]. Ekonal. Y 9179. Yellow cryst. Mp 158–159°.Google Scholar
  764. Ger. Pat., 2 403 416, (1974); CA, 84, 44045g (synth, pharmacol)Google Scholar
  765. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 19584.Google Scholar
  766. Eur. Pat., 232 937, (1987); CA, 108, 21891 (synth, pharmacol)Google Scholar
  767. U.S.P., 4 444 788, (1984); CA, 101, 151672 (synth, pharmacol) Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 3146.Google Scholar
  768. Atassi, G. et al, Eur. J. Cancer, 1975, 11, 599 (pharmacol)Google Scholar
  769. Raeymaekers, A. et al, Arzneim.-Forsch., 1978, 28, 586 (synth, pharmacol)Google Scholar
  770. Ger. Pat., 2 313 227, (1973); CA, 79, 146393h (synth, pharmacol)Google Scholar
  771. Ger. Pat., 2 522 533, (1975); CA, 84, 122148j (synth, pharmacol)Google Scholar
  772. Paris, J. et al, Arzneim.-Forsch., 1983, 33, 710 (acetate,pharmacol)Google Scholar
  773. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 3147.Google Scholar
  774. Bhuyan, B.K., Antibiotics (N.Y.), 1967, 1, 173 (rev)Google Scholar
  775. Wiley, P.F. et al, Tetrahedron Lett., 1968, 663 (isol, uv, ir, nmr)Google Scholar
  776. Wiley, P.F. et al, J. Am. Chem. Soc., 1977, 99, 542 (struct, ir, uv, ms, pmr, cmr)Google Scholar
  777. Wiley, P.F. et al, J. Org. Chem., 1979, 44, 4030 (abs config, cd, bibi)Google Scholar
  778. Bates, M.A. et al, J. Chem. Soc., Chem. Commun., 1983, 896 (synth)Google Scholar
  779. Arora, S.K., J. Am. Chem. Soc., 1983, 105, 1328 (cryst struct)Google Scholar
  780. Sax, N.I., Dangerous Properties of Industrial Materials, 6th Ed., Van Nostrand-Reinhold, 1984, 2067.Google Scholar
  781. Alaimo, R.J. et al, J. Med. Chem., 1975, 18, 1145 (synth, pharmacol, nmr, uv, ir, ms)Google Scholar
  782. Goldenberg, M.M. et al, Arch. Int. Pharmacodyn. Ther., 1977, 228, 153; 1980, 247, 163 (pharmacol)Google Scholar
  783. Ger. Pat., 2 550 005, (1976); CA, 85, 108546b (synth, pharmacol)Google Scholar
  784. Ger. Pat., 565 158, (1933); CA, 27, 1008 (synth)Google Scholar
  785. Org. Synth., 1933, 13, 4 (synth)Google Scholar
  786. Mowry, D.T. et al, J. Am. Chem. Soc., 1950, 72, 4439 (synth)Google Scholar
  787. Mowry, D.T. et al, Org. Synth., Coll. Vol., 4, 62 (nitrile)Google Scholar
  788. Housty, J. et al, Acta Crystallogr., 1967, 22, 288 (cryst struct)Google Scholar
  789. Mingrone, G. et al, Drugs Exp. Clin. Res., 1983, 9, 447 (tox)Google Scholar
  790. Breathnach, A.S. et al, Br. J. Dermatol., 1984, 111, 115 (rev, pharmacol)Google Scholar
  791. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 14036.Google Scholar
  792. Sax, N.I., Dangerous Properties of Industrial Materials, 6th Ed., Van Nostrand-Reinhold, 1984, 334.Google Scholar
  793. Grogan, C.H. et al, J. Med. Chem., 1967, 10, 621 (synth, pharmacol)Google Scholar
  794. Dirnhuber, P. et al, J. Physiol., 1965, 178, 41P (pharmacol)Google Scholar
  795. Friedrich, H. et al, Naturwissenschaften, 1965, 52, 514.CrossRefGoogle Scholar
  796. Ger. Pat., 1 213 855, (1966); CA, 64, 19504h (synth)Google Scholar
  797. Todd, P. et al, J. Chromatogr. Sci., 1975, 13, 577 (tic)Google Scholar
  798. U.S.P., 2 313 477, (1940)Google Scholar
  799. Enyeart, C.R., Nonionic Surfactants, Dekker, N.Y., 1967, 44 (rev)Google Scholar
  800. Calandra, J.C. et al, Toxicol. Appl. Pharmacol., 1969, 14, 315 (tox)Google Scholar
  801. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 450.Google Scholar
  802. Billings, R.E. et al, Life Sci., 1974, 14, 1437 (synth, pharmacol)Google Scholar
  803. Montzka, T.A. et al, Tetrahedron Lett., 1974, 1325 (synth)Google Scholar
  804. Booher, R.N. et al, J. Med. Chem., 1975, 18, 266 (synth)Google Scholar
  805. Chatterjie, N. et al, J. Med. Chem., 1975, 18, 630 (synth, ir, ms, pmr)Google Scholar
  806. Young, G.A. et al, Drug Alcohol Depend., 1978, 3, 273 (pharmacol)Google Scholar
  807. Smit, A.L.C. et al, Biomed. Mass Spectrom., 1978, 5, 572 (ms)Google Scholar
  808. Biel, J.H. et al, J. Am. Chem. Soc., 1954, 76, 3149 (synth, pharmacol)Google Scholar
  809. Waalkes, T.P. et al, Science, 1958, 127, 648 (isol)Google Scholar
  810. Pratesi, P. et al, J. Chem. Soc., 1959, 4062 (abs config)Google Scholar
  811. Levy, B. et al, Drill’s Pharmacology, 1971, McGraw-Hill, N.Y., 4th Ed., 627 (rev, pharmacol)Google Scholar
  812. Applewhite, P.B., Phytochemistry, 1973, 12, 191 (occur)Google Scholar
  813. Donike, M., Chromatographie, 1974, 7, 651 (ms)Google Scholar
  814. Andersen, A.M., Acta Chem. Scand., Ser. B, 1975, 29, 871 (cryst struct)Google Scholar
  815. Rajan, K.S. et al, Bioinorg. Chem., 1976, 6, 93 (uv)Google Scholar
  816. Smith, T.A., Phytochemistry, 1977, 16, 9 (occur, bibi)Google Scholar
  817. Wilson, T.D. et al, Anal. Profiles Drug Subst., 1982, 11, 555 (rev)Google Scholar
  818. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 2087.Google Scholar
  819. Sax, N.I., Dangerous Properties of Industrial Materials, 6th Ed., Van Nostrand-Reinhold, 1984, 2071, 2072.Google Scholar
  820. Edgren, R.A. et al, Steroids, 1963, 2, 731 (pharmacol)Google Scholar
  821. Smith, H., J. Chem. Soc., 1964, 4472 (synth, pharmacol)Google Scholar
  822. B.P., 1 037 658, (1966); CA, 66, 2371h (synth, pharmacol)Google Scholar
  823. Colton, F.B. et al, J. Am. Chem. Soc., 1957, 79, 1123 (synth)Google Scholar
  824. Junkmann, K. et al, Arzneim.-Forsch., 1962, 12, 214 (pharmacol)Google Scholar
  825. Caspi, E. et al, Can. J. Chem., 1963, 41, 2294 (pmr)Google Scholar
  826. Smith, H. et al, J. Chem. Soc., 1964, 4472 (synth)Google Scholar
  827. Zaretskii, V.I. et al, Tetrahedron, 1968, 24, 2339 (ms)Google Scholar
  828. Boris, A. et al, Steroids, 1970, 15, 61 (pharmacol)Google Scholar
  829. U.S.P., 3 959 322, (1976); CA, 85, 94611 (synth)Google Scholar
  830. Ward, R.J. et al, J. Steroid Biochem., 1977, 8, 1057 (metab)Google Scholar
  831. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 9075.Google Scholar
  832. Djerassi, C. et al, J. Am. Chem. Soc., 1954, 76, 4092 (synth)Google Scholar
  833. Siemann, H.J. et al, J. Prakt. Chem., 1969, 311, 671 (synth)Google Scholar
  834. Michnowicz, J. et al, Org. Mass Spectrom., 1972, 6, 765 (ms)Google Scholar
  835. Brogden, R.N. et al, Drugs, 1973, 6, 169 (rev)Google Scholar
  836. Schroff, A.P. et al, J. Med. Chem., 1973, 16, 113 (acetate oxime)Google Scholar
  837. Schroff, A.P. et al, Anal. Profiles Drug Subst., 1975, 4, 268 (rev)Google Scholar
  838. Mornon, J.P. et al, C.R. Hebd. Seances Acad. Sci., Ser. C, 1976, 282, 387 (cryst struct)Google Scholar
  839. Nishino, Y. et al, Arzneim.-Forsch., 1980, 30, 439 (enanthate)Google Scholar
  840. Huempel, M. et al, Contraception, 1982, 26, 83 (rev, metab)Google Scholar
  841. Lal, K. et al, Indian J. Chem., Sect. B, 1982, 21, 682 (enanthate)Google Scholar
  842. Baier, H. et al, HeIv. Chim. Acta, 1985, 68, 1054 (synth, cd)Google Scholar
  843. Leung, S.L. et al, Steroids, 1985, 46, 639 (synth)Google Scholar
  844. Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th Ed., Akademie-Verlag, Berlin, 1987, 5844, 6627, 7586 (synonyms)Google Scholar
  845. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 9076, 9077, 9078.Google Scholar
  846. U.S.P., 2 691 028, (1955); CA, 49, 11729 (synth)Google Scholar
  847. U.S.P., 2 725 389, (1956); CA, 50, 9455 (synth)Google Scholar
  848. Palmer, K.H. et al, J. Pharmacol. Exp. Ther., 1969, 167, 207.Google Scholar
  849. Cook, C.E. et al, J. Pharmacol. Exp. Ther., 1972, 183, 197.Google Scholar
  850. Drill, V.A., J. Toxicol. Environ. Health, 1977, 3, 133, 139 (revs)Google Scholar
  851. McPhail, A.T. et al, J. Chem. Soc., Perkin Trans. 2, 1977, 379 (cryst struct)Google Scholar
  852. Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th Ed., Akademie-Verlag, Berlin, 1987, 5845 (synonyms) Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 9079.Google Scholar
  853. Koga, H. et al, J. Med. Chem., 1980, 23, 1358 (synth)Google Scholar
  854. Goneftou, Y. et al, C.R. Hebd. Seances Acad. Sci., 1981, 292, 37.Google Scholar
  855. Hirai, K. et al, Antimicrob. Agents Chemother., 1981, 19, 188 (pharmacol)Google Scholar
  856. Irikura, T. et al, Chemotherapy (Tokyo), Suppl. 4, 1981, 29, 766 (tox)Google Scholar
  857. Burnie, J., Drugs of Today, 1984, 20, 391 (rev)Google Scholar
  858. Pauliulconis, L.T. et al, J. Pharm. Sci., 1984, 73, 99 (hplc)Google Scholar
  859. Wise, R., J. Antimicrob. Chemother., 1984, 13 (Suppl. B), 59 (rev)Google Scholar
  860. Toffoli, P. et al, Acta Crystallogr., Sect. C, 1987, 43, 1745 (Pefloxacin, cryst struct)Google Scholar
  861. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 12349, 16941.Google Scholar
  862. Hiscock, A.K. et al, J. Chem. Soc., 1965, 5772 (synth)Google Scholar
  863. Ruggieri, R. et al, Steroids, 1965, 5, 73 (pharmacol)Google Scholar
  864. Ger. Pat., 2 633 210, (1977); CA, 86, 190343k (synth, pharmacol)Google Scholar
  865. Hahn, D.W. et al, Contraception, 1977, 16, 541 (pharmacol)Google Scholar
  866. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 13031.Google Scholar
  867. Ger. Pat., 1 813 083, (1969); CA, 72, 44026 (synth)Google Scholar
  868. Gilbert, H.G. et al, Steroids, 1974, 23, 585 (pharmacol)Google Scholar
  869. Smith, H. et al, J. Chem. Soc., 1964, 4472 (synth)Google Scholar
  870. Rosenberger, M. et al, Helv. Chim. Acta, 1971, 54, 2857 (synth)Google Scholar
  871. DeAngelis, N.J. et al, Acta Crystallogr., Sect. B, 1975, 31, 2040 (struct)Google Scholar
  872. Sauer, G. et al, Angew. Chem. Int. Ed. Engl., 1975, 14, 417 (synth)Google Scholar
  873. Sopirak, A. et al, Anal. Profiles Drug Subst., 1975, 4, 294 (rev)Google Scholar
  874. Ranney, R.E., J. Toxicol. Environ. Health, 1977, 3, 139 (rev, metab)Google Scholar
  875. Horvath, G. et al, Adv. Mass Spectrom., 1978, 7B, 1280 (ms)Google Scholar
  876. Jones, R.C. et al, Int. J. Fertil., 1979, 24, 39 (props, enantiomers)Google Scholar
  877. Baier, H. et al, Hely. Chim. Acta, 1985, 68, 1054 (synth, cd, abs config, nomencl)Google Scholar
  878. Cleve, G. et al, Arzneim.-Forsch., 1986, 36, 784 (mol struct)Google Scholar
  879. Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th Ed., Akademie-Verlag, Berlin, 1987, 6287, 6288.Google Scholar
  880. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 9080, 9081.Google Scholar
  881. Sax, N.I., Dangerous Properties of Industrial Materials, 6th Ed., Van Nostrand-Reinhold, 1984, 2072.Google Scholar
  882. Nomine, G. et al, C.R. Hebd. Seances Acad. Sci., 1965, 260, 4545 (synth, pharmacol)Google Scholar
  883. Lepicard, G. et al, Acta Crystallogr., Sect. B, 1974, 30, 2751 (cryst struct)Google Scholar
  884. Puech, A. et al, J. Chromatogr., 1975, 108, 345 (tic)Google Scholar
  885. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 13032.Google Scholar
  886. Mason, A.T. et al, J. Chem. Soc., 1894, 191 (synth)Google Scholar
  887. Cohen, M.D. et al, J. Chem. Soc. (B), 1967, 321 (uv)Google Scholar
  888. Percy, G.C. et al, J. Inorg. Nucl. Chem., 1972, 34, 3369 (irnmr)Google Scholar
  889. Djerassi, C. et al, J. Am. Chem. Soc., 1954, 76, 4092 (synth, pharmacol)Google Scholar
  890. Grunwell, J.F. et al, Steroids, 1976, 27, 759 (synth, pharmacol, ir, pmr)Google Scholar
  891. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 9082.Google Scholar
  892. Weijlard, J. et al, J. Am. Chem. Soc., 1942, 64, 869 (synth)Google Scholar
  893. Bentley, K.W., Chemistry of the Morphine Alkaloids, Oxford Univ. Press, 1954, 25, 69 (bibi)Google Scholar
  894. Adler, T.K., J. Pharmacol. Exp. Ther., 1963, 140, 155 (pharmacol, norcodeine)Google Scholar
  895. Kutter, E. et al, J. Med. Chem., 1970, 13, 801 (activity)Google Scholar
  896. Abdel-Monem, M.M. et al, J. Med. Chem., 1972, 15, 208 (synth, activity, norcodeine)Google Scholar
  897. Rice, K.C., J. Org. Chem., 1975, 40, 1850.CrossRefGoogle Scholar
  898. Frederickson, R.C. et al, Life Sci., 1976, 19, 1 181 (pharmacol)Google Scholar
  899. Rice, K.C., J. Heterocycl. Chem., 1977, 14, 665 (synth, noreodeine)Google Scholar
  900. Yeh, S.Y. et al, J. Pharm. Sci., 1978, 67, 878 (metab)Google Scholar
  901. Ghozland, F. et al, Eur. J. Med. Chem.-Chim. Ther., 1983, 18, 22 (pmr)Google Scholar
  902. Galligan, J.J. et al, J. Pharmacol. Exp. Ther., 1984, 229, 641 (pharmacol)Google Scholar
  903. lorio, M.A. et al, Eur. J. Med. Chem.-Chim. Ther., 1984, 19, 11 (synth)Google Scholar
  904. Fr. Pat., 1 455 048, (1966); CA, 66, 95096k (synth, pharmacol)Google Scholar
  905. Schmitt, J. et al, Chim. Ther., 1967, 2, 254(synth)Google Scholar
  906. Hoffsommer, R.D. et al, J. Org. Chem., 1962, 27, 4134; J. Med. Chem., 1965, 8, 555 (synth)Google Scholar
  907. Ger. Pat., 1 243 180, (1967); CA, 68, 2743x (Amitryptylinoxide)Google Scholar
  908. Hale, J.L., Anal. Profiles Drug Subst., 1972, 1, 233 (rev, Nortriptyline)Google Scholar
  909. Kassau, E., Deut. Apoth.-Ztg., 1973, 113, 1332 (cryst struct)Google Scholar
  910. Saferstein, R. et al, J. Assoc. Off. Anal. Chem., 1973, 56, 1284 (ms)Google Scholar
  911. Blessel, K.W., Anal. Profiles Drug. Subst., 1974, 3, 127 (Amitryptyline, rev)Google Scholar
  912. Siek, T.J., J. Forensic Sci., 1974, 19, 193 (uv)Google Scholar
  913. Sjoqvist, F., Acta Pharm. Suec., 1974, 11, 661 (rev, pharmacol)Google Scholar
  914. Down, G.J. et al, J. Chromatogr., 1975, 103, 208 (ms, deriv)Google Scholar
  915. Wenzl, H. et al, Arzneim.-Forsch., 1978, 28, 1873 (Amitriptylinoxide)Google Scholar
  916. Hyttel, J. et al, Acta Pharmacol. Toxicol., 1980, 47, 53 (pharmacol)Google Scholar
  917. Miodownik, A. et al, Synth. Commun., 1981, 11, 241 (synth)Google Scholar
  918. Martindale, The Extra Pharmacopoeia, 28th/29th Eds.Google Scholar
  919. /1989, Pharmaceutical Press, London, 2530, 2502, 2501.Google Scholar
  920. Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th Ed., Akademie-Verlag, Berlin, 1987, 5229, 5689.Google Scholar
  921. Saudoval, A. et al, J. Am. Chem. Soc., 1953, 75, 4117 (synth)Google Scholar
  922. Saunders, F.J. et al, Endocrinology, 1956, 58, 567 (pharmacol)Google Scholar
  923. Eur. Pat., 9 155, (1980); CA, 93, 168308a (synth, pharmacol)Google Scholar
  924. Bessodes, M. et al, Tetrahedron Lett., 1984, 25, 5899 (synth)Google Scholar
  925. Pfadenhauer, E.H. et al, Drug Metab. Dispos., 1984, 12, 280 (metab)Google Scholar
  926. Simon, L.N. et al, Immunol. Ser., 1984, 25, 475 (rev)Google Scholar
  927. Exon, J.H. et al, Fundam. Appl. Toxicol., 1986, 7, 387 (lox) Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 19591.Google Scholar
  928. Depaire, H. et al, Tetrahedron Lett., 1977, 1395, 1397, 1401, 1403 (struct, nmr, ir, uv)Google Scholar
  929. Pascard, C. et al, J. Am. Chem. Soc., 1977, 99, 6418 (cryst struct)Google Scholar
  930. Endo, T. et al, J. Antibiot., 1978, 31, 623 (struct, ir, cmr)Google Scholar
  931. Benazet, F. et al, Experientia, 1980, 36, 414 (rev)Google Scholar
  932. Japan. Pat., 81 127 092, (1981); CA, 96, 33357 (isol)Google Scholar
  933. Iwakawa, M. et al, Chem. Lett., 1982, 1975 (synth)Google Scholar
  934. Eur. Pat., 73 329, (1983); CA, 99, 37103 (isol)Google Scholar
  935. Houck, D.R. et al, J. Am. Chem. Soc., 1987, 109, 1250 (biosynth)Google Scholar
  936. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 13034.Google Scholar
  937. Hinman, J.W. et al, J. Am. Chem. Soc., 1956, 78, 1072, 2019; 1957, 79, 3789 (isol, struct)Google Scholar
  938. Shunk, C.H. et al, J. Am. Chem. Soc., 1956, 78, 1770, 2655, 5454 (isol, struct)Google Scholar
  939. Vaterlans, B.P. et al, Hely. Chim. Acta, 1964, 47, 390 (synth, ir, uv)Google Scholar
  940. Gracheva, I.V. et al, Antibiotiki (Moscow), 1966, 11, 45; CA, 65, 2961 (isol, Isonovobiocin, Descarbamylnovobiocin)Google Scholar
  941. Brock, T.D., Antibiotics (N.Y.), 1967, 1, 671 (rev)Google Scholar
  942. Calvert, R.T. et al, J. Pharm. Pharmacol., 1972, 24, 972 (biosynth)Google Scholar
  943. Boles, M.O. et al, Acta Crystallogr., Sect. B, 1975, 31, 1400 (cryst struct)Google Scholar
  944. Achmatowicz, O. et al, Tetrahedron, 1976, 32, 1051 (struct)Google Scholar
  945. Dolak, L., J. Antibiot., 1976, 29, 710 (cmr)Google Scholar
  946. Berger, J. et al, J. Chromatogr. Libr., 1978, 15, 101 (rev)Google Scholar
  947. Ryan, M.J., Antibiotics (N.Y.), 1979, 5, 214 (rev)Google Scholar
  948. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 115.Google Scholar
  949. Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th Ed., Akademie-Verlag, Berlin, 1987, 7910.Google Scholar
  950. Sax, N.I., Dangerous Properties of Industrial Materials, 6th Ed., Van Nostrand-Reinhold, 1984, 2075.Google Scholar
  951. Hoffmeister, F., Arzneim.-Forsch., 1969, 19, 838 (synth, pharmacol)Google Scholar
  952. Bandoli, G. et al, J. Crystallogr. Spectrosc. Res., 1983, 13, 191 (cryst struct)Google Scholar
  953. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 2531.Google Scholar
  954. Eur. Pat., 50 671, (1982); CA, 96, 162337z (synth, pharmacol)Google Scholar
  955. Komoriya, K. et al, Jpn. J. Pharmacol., 1987, 45, 389 (pharmacol)Google Scholar
  956. Adelstein, G.W. et al, J. Med. Chem., 1976, 19, 1221 (synth, pharmacol)Google Scholar
  957. Mackerer, C.R. et al, J. Am. Coll. Toxicol., 1983, 3, 81 (rev)Google Scholar
  958. Eur. Pat., 125 607, (1984); CA, 102, 220855 (synth)Google Scholar
  959. U.S.P., 3 790 605, (/974); CA, 80, 121211e (synth, pharmacol)Google Scholar
  960. B.P., 714 189, (1955); CA, 49, 4242 (isol)Google Scholar
  961. Walter, D.R. et al, J. Am. Chem. Soc., 1957, 79, 5076 (struct)Google Scholar
  962. Mainwaring, D.G. et al, Tetrahedron Lett., 1969, 5319 (struct)Google Scholar
  963. Chong, C.N. et al, Tetrahedron Lett., 1970, 5145 (struct)Google Scholar
  964. Michel, G.W., Anal. Profiles Drug Subst., 1977, 6, 341 (rev)Google Scholar
  965. Pandey, R.C. et al, J. Antibiot., 1977, 30, 158 (synth)Google Scholar
  966. Holz, R.W., Antibiotics (N.Y.), 1979, 5, 313 (rev)Google Scholar
  967. Travkin, O.V. et al, Antibiotiki (Moscow), 1981, 26, 519 (props)Google Scholar
  968. Coline, A. et al, J. Antibiot., 1985, 38, 181 (spectra)Google Scholar
  969. Peterson, N.O. et al, Can. J. Chem., 1985, 63, 77 (spectra)Google Scholar
  970. Martindale, The Extra Pharmacopoeia, 28th/29th Eds., 1982/1989, Pharmaceutical Press, London, 2596.Google Scholar
  971. Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th Ed., Akademie-Verlag, Berlin, 1987, 8257.Google Scholar
  972. Sax, N.I., Dangerous Properties of Industrial Materials, 5th Ed., Van Nostrand-Reinhold, 1979, 2077.Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1990

Authors and Affiliations

  • J. Elks
  • C. R. Ganellin

There are no affiliations available

Personalised recommendations